ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||
immune response
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADAMDEC1 | ADAM-like, decysin 1 |
|
NAS | 8 | 24,241,798 | 24,263,526 | RGD:2290271 | UniProtKB | ||
| G | AIM2 | absent in melanoma 2 |
|
TAS | 1 | 159,032,275 | 159,046,647 | RGD:2290271 | PINC | ||
| G | AIRE | autoimmune regulator |
|
TAS | 21 | 45,705,721 | 45,718,102 | RGD:2290271 | PINC | ||
| G | APLN | apelin |
|
TAS | X | 128,779,236 | 128,788,933 | RGD:2290271 | PINC | ||
| G | AQP9 | aquaporin 9 |
|
TAS | 15 | 58,430,408 | 58,478,110 | RGD:2290271 | PINC | ||
| G | ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta |
|
TAS | 12 | 15,094,950 | 15,114,562 | RGD:2290271 | PINC | ||
| G | ATP6V0A2 | ATPase, H+ transporting, lysosomal V0 subunit a2 |
|
TAS | 12 | 124,196,865 | 124,246,302 | RGD:2290271 | PINC | ||
| G | AZGP1 | alpha-2-glycoprotein 1, zinc-binding |
|
IEA | 7 | 99,564,350 | 99,573,735 | RGD:2290271 | InterPro | ||
| G | B2M | beta-2-microglobulin |
|
NAS | 15 | 45,003,685 | 45,010,357 | RGD:2290271 | UniProtKB | ||
| G | B2M | beta-2-microglobulin |
|
IEA | 15 | 45,003,685 | 45,010,357 | RGD:2290271 | InterPro | ||
| G | BCAP31 | B-cell receptor-associated protein 31 |
|
IEA | X | 152,965,947 | 152,990,201 | RGD:2290271 | ENSEMBL | ||
| G | BCAP31 | B-cell receptor-associated protein 31 |
|
NAS | X | 152,965,947 | 152,990,201 | RGD:2290271 | UniProtKB | ||
| G | BMP6 | bone morphogenetic protein 6 |
|
IMP | 6 | 7,727,011 | 7,881,961 | RGD:2290271 | BHF-UCL | ||
| G | BMPR1A | bone morphogenetic protein receptor, type IA |
|
IMP | 10 | 88,516,396 | 88,684,945 | RGD:2290271 | BHF-UCL | ||
| G | BPI | bactericidal/permeability-increasing protein |
|
IEA | 20 | 36,932,552 | 36,965,905 | RGD:2290271 | ENSEMBL | ||
| G | C1QBP | complement component 1, q subcomponent binding protein |
|
TAS | 17 | 5,336,099 | 5,342,471 | RGD:2290271 | PINC | ||
| G | C1QC | complement component 1, q subcomponent, C chain |
|
NAS | 1 | 22,970,118 | 22,974,603 | RGD:2290271 | UniProtKB | ||
| G | C1R | complement component 1, r subcomponent |
|
TAS | 12 12 |
7,241,205 7,187,513 |
7,245,043 7,189,412 |
RGD:2290271 | PINC | ||
| G | C3 | complement component 3 |
|
TAS | 19 | 6,677,846 | 6,720,662 | RGD:2290271 | PINC | ||
| G | C5AR1 | complement component 5a receptor 1 |
|
TAS | 19 | 47,813,104 | 47,825,327 | RGD:2290271 | PINC | ||
| G | C8A | complement component 8, alpha polypeptide |
|
TAS | 1 | 57,320,443 | 57,383,894 | RGD:2290271 | PINC | ||
| G | C8B | complement component 8, beta polypeptide |
|
TAS | 1 | 57,394,883 | 57,431,688 | RGD:2290271 | PINC | ||
| G | C8B | complement component 8, beta polypeptide |
|
IEA | 1 | 57,394,883 | 57,431,688 | RGD:2290271 | InterPro | ||
| G | CBLB | Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
IEA | 3 | 105,377,109 | 105,587,887 | RGD:2290271 | ENSEMBL | ||
| G | CCBP2 | chemokine binding protein 2 |
|
TAS | 3 | 42,850,964 | 42,908,775 | RGD:2290271 | PINC | ||
| G | CCL1 | chemokine (C-C motif) ligand 1 |
|
IEA | 17 | 32,687,399 | 32,690,252 | RGD:2290271 | InterPro | ||
| G | CCL11 | chemokine (C-C motif) ligand 11 |
|
IEA | 17 | 32,612,687 | 32,615,199 | RGD:2290271 | InterPro | ||
| G | CCL13 | chemokine (C-C motif) ligand 13 |
|
IEA | 17 | 32,683,471 | 32,685,629 | RGD:2290271 | InterPro | ||
| G | CCL13 | chemokine (C-C motif) ligand 13 |
|
IEA | 17 | 32,683,471 | 32,685,629 | RGD:2290271 | InterPro | ||
| G | CCL14 | chemokine (C-C motif) ligand 14 |
|
IEA | 17 | 34,310,692 | 34,313,764 | RGD:2290271 | InterPro | ||
| G | CCL15 | chemokine (C-C motif) ligand 15 |
|
IEA | 17 | 34,324,618 | 34,329,084 | RGD:2290271 | InterPro | ||
| G | CCL15 | chemokine (C-C motif) ligand 15 |
|
IEA | 17 | 34,324,618 | 34,329,084 | RGD:2290271 | InterPro | ||
| G | CCL16 | chemokine (C-C motif) ligand 16 |
|
IEA | 17 | 34,303,535 | 34,308,523 | RGD:2290271 | InterPro | ||
| G | CCL17 | chemokine (C-C motif) ligand 17 |
|
IEA | 16 | 57,438,679 | 57,449,974 | RGD:2290271 | InterPro | ||
| G | CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) |
|
IEA | 17 | 34,391,643 | 34,398,841 | RGD:2290271 | InterPro | ||
| G | CCL19 | chemokine (C-C motif) ligand 19 |
|
IEA | 9 | 34,689,567 | 34,691,274 | RGD:2290271 | InterPro | ||
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
IEA | 17 | 32,582,296 | 32,584,222 | RGD:2290271 | InterPro | ||
| G | CCL20 | chemokine (C-C motif) ligand 20 |
|
IEA | 2 | 228,678,558 | 228,682,280 | RGD:2290271 | InterPro | ||
| G | CCL21 | chemokine (C-C motif) ligand 21 |
|
IEA | 9 | 34,709,002 | 34,710,147 | RGD:2290271 | InterPro | ||
| G | CCL22 | chemokine (C-C motif) ligand 22 |
|
IEA | 16 | 57,392,695 | 57,400,102 | RGD:2290271 | InterPro | ||
| G | CCL23 | chemokine (C-C motif) ligand 23 |
|
IEA | 17 | 34,340,097 | 34,345,005 | RGD:2290271 | InterPro | ||
| G | CCL24 | chemokine (C-C motif) ligand 24 |
|
IEA | 7 | 75,441,114 | 75,443,033 | RGD:2290271 | InterPro | ||
| G | CCL25 | chemokine (C-C motif) ligand 25 |
|
IEA | 19 | 8,117,646 | 8,127,547 | RGD:2290271 | InterPro | ||
| G | CCL26 | chemokine (C-C motif) ligand 26 |
|
IEA | 7 | 75,398,842 | 75,419,064 | RGD:2290271 | InterPro | ||
| G | CCL27 | chemokine (C-C motif) ligand 27 |
|
IEA | 9 | 34,661,893 | 34,662,689 | RGD:2290271 | InterPro | ||
| G | CCL28 | chemokine (C-C motif) ligand 28 |
|
IEA | 5 | 43,381,600 | 43,412,488 | RGD:2290271 | InterPro | ||
| G | CCL28 | chemokine (C-C motif) ligand 28 |
|
IEA | 5 | 43,381,600 | 43,412,488 | RGD:2290271 | InterPro | ||
| G | CCL3L1 | chemokine (C-C motif) ligand 3-like 1 |
|
IEA | 17 | 34,623,842 | 34,625,730 | RGD:2290271 | InterPro | ||
| G | CCL3L3 | chemokine (C-C motif) ligand 3-like 3 |
|
IEA | 17 | 34,522,268 | 34,524,147 | RGD:2290271 | InterPro | ||
| G | CCL4 | chemokine (C-C motif) ligand 4 |
|
IEA | 17 | 34,431,220 | 34,433,014 | RGD:2290271 | InterPro | ||
| G | CCL4L1 | chemokine (C-C motif) ligand 4-like 1 |
|
IEA | 17 | 34,538,468 | 34,540,275 | RGD:2290271 | InterPro | ||
| G | CCL4L1 | chemokine (C-C motif) ligand 4-like 1 |
|
IEA | 17 | 34,538,468 | 34,540,275 | RGD:2290271 | InterPro | ||
| G | CCL4L2 | chemokine (C-C motif) ligand 4-like 2 |
|
IEA | 17 | 34,640,034 | 34,641,841 | RGD:2290271 | InterPro | ||
| G | CCL5 | chemokine (C-C motif) ligand 5 |
|
IEA | 17 | 34,198,495 | 34,207,377 | RGD:2290271 | InterPro | ||
| G | CCL7 | chemokine (C-C motif) ligand 7 |
|
IEA | 17 | 32,597,240 | 32,599,256 | RGD:2290271 | InterPro | ||
| G | CCL8 | chemokine (C-C motif) ligand 8 |
|
IEA | 17 | 32,646,066 | 32,648,421 | RGD:2290271 | InterPro | ||
| G | CCR1 | chemokine (C-C motif) receptor 1 |
|
IDA | 3 | 46,243,200 | 46,249,832 | RGD:2290271 | UniProtKB | ||
| G | CCR10 | chemokine (C-C motif) receptor 10 |
|
IEA | 17 | 40,831,420 | 40,833,845 | RGD:2290271 | InterPro | ||
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
IEA | 3 | 46,395,235 | 46,402,413 | RGD:2290271 | InterPro | ||
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
TAS | 3 | 46,395,235 | 46,402,413 | RGD:2290271 | PINC | ||
| G | CCR4 | chemokine (C-C motif) receptor 4 |
|
IEA | 3 | 32,993,066 | 32,996,403 | RGD:2290271 | InterPro | ||
| G | CCR5 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
|
IEA | 3 | 46,411,633 | 46,417,697 | RGD:2290271 | InterPro | ||
| G | CCR6 | chemokine (C-C motif) receptor 6 |
|
TAS | 6 | 167,525,295 | 167,552,629 | RGD:2290271 | PINC | ||
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
IEA | 17 | 38,710,021 | 38,721,736 | RGD:2290271 | ENSEMBL | ||
| G | CCR8 | chemokine (C-C motif) receptor 8 |
|
IEA | 3 | 39,371,197 | 39,375,171 | RGD:2290271 | InterPro | ||
| G | CCR9 | chemokine (C-C motif) receptor 9 |
|
IEA | 3 | 45,927,996 | 45,944,667 | RGD:2290271 | InterPro | ||
| G | CCRL1 | chemokine (C-C motif) receptor-like 1 |
|
TAS | 3 | 132,316,094 | 132,321,382 | RGD:2290271 | PINC | ||
| G | CD164 | CD164 molecule, sialomucin |
|
TAS | 6 | 109,687,717 | 109,703,762 | RGD:2290271 | PINC | ||
| G | CD1A | CD1a molecule |
|
NAS | 1 | 158,223,927 | 158,228,059 | RGD:2290271 | UniProtKB | ||
| G | CD1B | CD1b molecule |
|
IEA | 1 | 158,297,740 | 158,301,321 | RGD:2290271 | InterPro | ||
| G | CD1C | CD1c molecule |
|
IEA | 1 | 158,259,563 | 158,264,564 | RGD:2290271 | InterPro | ||
| G | CD1E | CD1e molecule |
|
NAS | 1 | 158,323,486 | 158,327,343 | RGD:2290271 | UniProtKB | ||
| G | CD1E | CD1e molecule |
|
IEA | 1 | 158,323,486 | 158,327,343 | RGD:2290271 | InterPro | ||
| G | CD274 | CD274 molecule |
|
IDA | 9 | 5,450,503 | 5,470,567 | RGD:2290271 | UniProtKB | ||
| G | CD276 | CD276 molecule |
|
NAS | 15 | 73,976,622 | 74,006,859 | RGD:2290271 | UniProtKB | ||
| G | CD28 | CD28 molecule |
|
IEA | 2 | 204,571,198 | 204,603,635 | RGD:2290271 | InterPro | ||
| G | CD4 | CD4 molecule |
|
NAS | 12 | 6,898,638 | 6,929,976 | RGD:2290271 | UniProtKB | ||
| G | CD40LG | CD40 ligand |
|
IEA | X | 135,730,336 | 135,742,549 | RGD:2290271 | InterPro | ||
| G | CD7 | CD7 molecule |
|
TAS | 17 | 80,272,746 | 80,275,480 | RGD:2290271 | UniProtKB | ||
| G | CD70 | CD70 molecule |
|
IEA | 19 | 6,585,850 | 6,591,163 | RGD:2290271 | InterPro | ||
| G | CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain |
|
IEA | 5 | 149,781,200 | 149,792,499 | RGD:2290271 | InterPro | ||
| G | CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain |
|
IEA | 5 | 149,781,200 | 149,792,499 | RGD:2290271 | InterPro | ||
| G | CD79B | CD79b molecule, immunoglobulin-associated beta |
|
TAS | 17 | 62,006,098 | 62,009,704 | RGD:2290271 | PINC | ||
| G | CD86 | CD86 molecule |
|
TAS | 3 | 121,774,209 | 121,839,990 | RGD:2290271 | PINC | ||
| G | CD8A | CD8a molecule |
|
NAS | 2 | 87,011,728 | 87,035,519 | RGD:2290271 | UniProtKB | ||
| G | CD8B | CD8b molecule |
|
NAS | 2 | 87,042,460 | 87,089,047 | RGD:2290271 | UniProtKB | ||
| G | CD96 | CD96 molecule |
|
TAS | 3 | 111,260,926 | 111,371,206 | RGD:2290271 | PINC | ||
| G | CD97 | CD97 molecule |
|
TAS | 19 | 14,491,956 | 14,519,537 | RGD:2290271 | PINC | ||
| G | CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 |
|
TAS | 19 | 43,084,395 | 43,099,082 | RGD:2290271 | PINC | ||
| G | CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
|
TAS | 20 | 48,807,120 | 48,809,227 | RGD:2290271 | PINC | ||
| G | CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma |
|
ISS | 19 | 33,864,575 | 33,873,592 | RGD:2290271 | UniProtKB | ||
| G | CFP | complement factor properdin |
|
TAS | X | 47,483,612 | 47,489,704 | RGD:2290271 | PINC | ||
| G | CHIA | chitinase, acidic |
|
NAS | 1 | 111,833,474 | 111,863,188 | RGD:2290271 | UniProtKB | ||
| G | CHIT1 | chitinase 1 (chitotriosidase) |
|
NAS | 1 | 203,185,207 | 203,198,860 | RGD:2290271 | UniProtKB | ||
| G | CHST4 | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 |
|
TAS | 16 | 71,560,023 | 71,572,493 | RGD:2290271 | PINC | ||
| G | CHUK | conserved helix-loop-helix ubiquitous kinase |
|
TAS | 10 | 101,948,124 | 101,989,344 | RGD:2290271 | PINC | ||
| G | CIITA | class II, major histocompatibility complex, transactivator |
|
TAS | 16 | 10,971,055 | 11,018,840 | RGD:2290271 | PINC | ||
| G | CLEC4E | C-type lectin domain family 4, member E |
|
IEA | 12 | 8,685,901 | 8,693,558 | RGD:2290271 | ENSEMBL | ||
| G | CLNK | cytokine-dependent hematopoietic cell linker |
|
NAS | 4 | 10,491,838 | 10,686,386 | RGD:2290271 | UniProtKB | ||
| G | CMKLR1 | chemokine-like receptor 1 |
|
TAS | 12 | 108,681,821 | 108,733,094 | RGD:2290271 | PINC | ||
| G | CNIH | cornichon homolog (Drosophila) |
|
TAS | 14 | 54,893,647 | 54,908,148 | RGD:2290271 | PINC | ||
| G | CNR2 | cannabinoid receptor 2 (macrophage) |
|
TAS | 1 | 24,200,460 | 24,239,817 | RGD:2290271 | PINC | ||
| G | COL4A3BP | collagen, type IV, alpha 3 (Goodpasture antigen) binding protein |
|
NAS | 5 | 74,666,928 | 74,807,806 | RGD:2290271 | UniProtKB | ||
| G | CR2 | complement component (3d/Epstein Barr virus) receptor 2 |
|
NAS | 1 | 207,627,645 | 207,663,240 | RGD:2290271 | UniProtKB | ||
| G | CRHR1 | corticotropin releasing hormone receptor 1 |
|
TAS | 17 | 43,697,710 | 43,913,194 | RGD:2290271 | PINC | ||
| G | CRIP1 | cysteine-rich protein 1 (intestinal) |
|
IEP | 14 | 105,953,257 | 105,955,126 | RGD:2290271 | UniProtKB | ||
| G | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
IEA | 5 | 131,409,485 | 131,411,863 | RGD:2290271 | InterPro | ||
| G | CSF3 | colony stimulating factor 3 (granulocyte) |
|
IEA | 17 | 38,171,614 | 38,174,066 | RGD:2290271 | InterPro | ||
| G | CST7 | cystatin F (leukocystatin) |
|
TAS | 20 | 24,929,866 | 24,940,564 | RGD:2290271 | PINC | ||
| G | CTLA4 | cytotoxic T-lymphocyte-associated protein 4 |
|
IEA | 2 | 204,732,511 | 204,738,683 | RGD:2290271 | InterPro | ||
| G | CTSC | cathepsin C |
|
TAS | 11 | 88,026,760 | 88,070,941 | RGD:2290271 | PINC | ||
| G | CTSG | cathepsin G |
|
TAS | 14 | 25,042,724 | 25,045,466 | RGD:2290271 | PINC | ||
| G | CTSS | cathepsin S |
|
TAS | 1 | 150,702,672 | 150,738,433 | RGD:2290271 | PINC | ||
| G | CTSW | cathepsin W |
|
TAS | 11 | 65,647,284 | 65,651,212 | RGD:2290271 | PINC | ||
| G | CX3CL1 | chemokine (C-X3-C motif) ligand 1 |
|
TAS | 16 | 57,406,414 | 57,418,956 | RGD:2290271 | UniProtKB | ||
| G | CX3CL1 | chemokine (C-X3-C motif) ligand 1 |
|
IEA | 16 | 57,406,414 | 57,418,956 | RGD:2290271 | InterPro | ||
| G | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
IEA | 4 | 74,735,109 | 74,737,019 | RGD:2290271 | InterPro | ||
| G | CXCL10 | chemokine (C-X-C motif) ligand 10 |
|
IEA | 4 | 76,942,269 | 76,944,689 | RGD:2290271 | ENSEMBL | ||
| G | CXCL11 | chemokine (C-X-C motif) ligand 11 |
|
IEA | 4 | 76,954,835 | 76,957,350 | RGD:2290271 | ENSEMBL | ||
| G | CXCL12 | chemokine (C-X-C motif) ligand 12 |
|
IEA | 10 | 44,865,605 | 44,880,545 | RGD:2290271 | InterPro | ||
| G | CXCL13 | chemokine (C-X-C motif) ligand 13 |
|
IC | 4 | 78,432,907 | 78,532,988 | RGD:2290271 | BHF-UCL | ||
| G | CXCL14 | chemokine (C-X-C motif) ligand 14 |
|
IEA | 5 | 134,906,369 | 134,914,969 | RGD:2290271 | InterPro | ||
| G | CXCL2 | chemokine (C-X-C motif) ligand 2 |
|
IEA | 4 | 74,962,752 | 74,964,997 | RGD:2290271 | InterPro | ||
| G | CXCL3 | chemokine (C-X-C motif) ligand 3 |
|
IEA | 4 | 74,902,306 | 74,904,490 | RGD:2290271 | InterPro | ||
| G | CXCL5 | chemokine (C-X-C motif) ligand 5 |
|
IEA | 4 | 74,861,359 | 74,864,416 | RGD:2290271 | InterPro | ||
| G | CXCL6 | chemokine (C-X-C motif) ligand 6 |
|
IEA | 4 | 74,702,273 | 74,704,477 | RGD:2290271 | InterPro | ||
| G | CXCL9 | chemokine (C-X-C motif) ligand 9 |
|
IEA | 4 | 76,922,623 | 76,928,641 | RGD:2290271 | InterPro | ||
| G | CXCR5 | chemokine (C-X-C motif) receptor 5 |
|
IEA | 11 | 118,754,475 | 118,766,980 | RGD:2290271 | InterPro | ||
| G | CYP11B1 | cytochrome P450, family 11, subfamily B, polypeptide 1 |
|
TAS | 8 | 143,953,773 | 143,961,236 | RGD:2290271 | BHF-UCL | ||
| G | CYSLTR2 | cysteinyl leukotriene receptor 2 |
|
NAS | 13 | 49,280,951 | 49,283,498 | RGD:2290271 | UniProtKB | ||
| G | DEFA1 | defensin, alpha 1 |
|
TAS | 8 | 6,835,171 | 6,837,614 | RGD:2290271 | PINC | ||
| G | DEFA1B | defensin, alpha 1B |
|
TAS | 8 | 6,854,288 | 6,856,724 | RGD:2290271 | PINC | ||
| G | DEFB1 | defensin, beta 1 |
|
TAS | 8 | 6,728,097 | 6,735,529 | RGD:2290271 | PINC | ||
| G | DEFB4A | defensin, beta 4A |
|
TAS | 8 | 7,752,199 | 7,754,237 | RGD:2290271 | PINC | ||
| G | DEFB4B | defensin, beta 4B |
|
TAS | 8 | 7,272,385 | 7,274,354 | RGD:2290271 | PINC | ||
| G | DPP8 | dipeptidyl-peptidase 8 |
|
TAS | 15 | 65,737,998 | 65,810,035 | RGD:2290271 | UniProtKB | ||
| G | EDA | ectodysplasin A |
|
IEA | X | 68,835,911 | 69,259,322 | RGD:2290271 | InterPro | ||
| G | ENDOU | endonuclease, polyU-specific |
|
IEA | 12 | 48,103,517 | 48,119,355 | RGD:2290271 | InterPro | ||
| G | ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
IEA | 6 | 132,129,156 | 132,216,295 | RGD:2290271 | InterPro | ||
| G | ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
IEA | 8 | 120,569,317 | 120,651,106 | RGD:2290271 | InterPro | ||
| G | ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
IEA | 8 | 120,569,317 | 120,651,106 | RGD:2290271 | InterPro | ||
| G | ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 |
|
IEA | 6 | 131,958,442 | 132,068,550 | RGD:2290271 | InterPro | ||
| G | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
TAS | 11 | 128,328,656 | 128,457,453 | RGD:2290271 | PINC | ||
| G | EXOSC9 | exosome component 9 |
|
NAS | 4 | 122,722,472 | 122,738,176 | RGD:2290271 | UniProtKB | ||
| G | FAS | Fas (TNF receptor superfamily, member 6) |
|
IEA | 10 | 90,750,288 | 90,775,542 | RGD:2290271 | InterPro | ||
| G | FASLG | Fas ligand (TNF superfamily, member 6) |
|
IEA | 1 | 172,628,185 | 172,636,013 | RGD:2290271 | InterPro | ||
| G | FCAR | Fc fragment of IgA, receptor for |
|
TAS | 19 | 55,385,549 | 55,401,839 | RGD:2290271 | PINC | ||
| G | FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
TAS | 1 | 149,754,250 | 149,764,074 | RGD:2290271 | PINC | ||
| G | FCGR1B | Fc fragment of IgG, high affinity Ib, receptor (CD64) |
|
NAS | 1 | 120,926,128 | 120,935,944 | RGD:2290271 | UniProtKB | ||
| G | FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
TAS | 1 | 161,632,905 | 161,648,444 | RGD:2290271 | PINC | ||
| G | FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) |
|
NAS | 1 | 161,551,129 | 161,571,010 | RGD:2290271 | UniProtKB | ||
| G | FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
|
TAS | 1 | 161,511,549 | 161,520,413 | RGD:2290271 | PINC | ||
| G | FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
|
TAS | 1 | 161,592,986 | 161,601,753 | RGD:2290271 | PINC | ||
| G | FCGRT | Fc fragment of IgG, receptor, transporter, alpha |
|
IEA | 19 | 50,015,536 | 50,029,685 | RGD:2290271 | InterPro | ||
| G | FTH1 | ferritin, heavy polypeptide 1 |
|
ISS | 11 | 61,731,757 | 61,735,132 | RGD:2290271 | UniProtKB | ||
| G | FYB | FYN binding protein |
|
TAS | 5 | 39,105,354 | 39,270,759 | RGD:2290271 | PINC | ||
| G | GBP2 | guanylate binding protein 2, interferon-inducible |
|
TAS | 1 | 89,573,310 | 89,591,799 | RGD:2290271 | PINC | ||
| G | GEM | GTP binding protein overexpressed in skeletal muscle |
|
TAS | 8 | 95,261,481 | 95,274,547 | RGD:2290271 | PINC | ||
| G | GPR183 | G protein-coupled receptor 183 |
|
TAS | 13 | 99,946,789 | 99,959,749 | RGD:2290271 | PINC | ||
| G | GPR65 | G protein-coupled receptor 65 |
|
TAS | 14 | 88,471,468 | 88,481,155 | RGD:2290271 | PINC | ||
| G | GTPBP1 | GTP binding protein 1 |
|
TAS | 22 | 39,101,807 | 39,129,592 | RGD:2290271 | PINC | ||
| G | GZMA | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
|
TAS | 5 | 54,398,474 | 54,406,080 | RGD:2290271 | UniProtKB | ||
| G | HAMP | hepcidin antimicrobial peptide |
|
TAS | 19 | 35,773,410 | 35,776,046 | RGD:2290271 | UniProtKB | ||
| G | HFE | hemochromatosis |
|
IEA | 6 | 26,087,509 | 26,095,469 | RGD:2290271 | InterPro | ||
| G | HLA-A | major histocompatibility complex, class I, A |
|
NAS | 6 | 29,910,247 | 29,913,661 | RGD:2290271 | UniProtKB | ||
| G | HLA-A | major histocompatibility complex, class I, A |
|
NAS | 6 | 29,910,247 | 29,913,661 | RGD:2290271 | UniProtKB | ||
| G | HLA-A | major histocompatibility complex, class I, A |
|
IMP | 6 | 29,910,247 | 29,913,661 | RGD:2290271 | UniProtKB | ||
| G | HLA-A | major histocompatibility complex, class I, A |
|
NAS | 6 | 29,910,247 | 29,913,661 | RGD:2290271 | UniProtKB | ||
| G | HLA-A | major histocompatibility complex, class I, A |
|
NAS | 6 | 29,910,247 | 29,913,661 | RGD:2290271 | UniProtKB | ||
| G | HLA-A | major histocompatibility complex, class I, A |
|
NAS | 6 | 29,910,247 | 29,913,661 | RGD:2290271 | UniProtKB | ||
| G | HLA-A | major histocompatibility complex, class I, A |
|
IEA | 6 | 29,910,247 | 29,913,661 | RGD:2290271 | InterPro | ||
| G | HLA-A | major histocompatibility complex, class I, A |
|
IEA | 6 | 29,910,247 | 29,913,661 | RGD:2290271 | InterPro | ||
| G | HLA-A | major histocompatibility complex, class I, A |
|
NAS | 6 | 29,910,247 | 29,913,661 | RGD:2290271 | UniProtKB | ||
| G | HLA-B | major histocompatibility complex, class I, B |
|
IMP | 6 | 31,321,649 | 31,324,989 | RGD:2290271 | UniProtKB | ||
| G | HLA-B | major histocompatibility complex, class I, B |
|
NAS | 6 | 31,321,649 | 31,324,989 | RGD:2290271 | UniProtKB | ||
| G | HLA-B | major histocompatibility complex, class I, B |
|
NAS | 6 | 31,321,649 | 31,324,989 | RGD:2290271 | UniProtKB | ||
| G | HLA-B | major histocompatibility complex, class I, B |
|
NAS | 6 | 31,321,649 | 31,324,989 | RGD:2290271 | UniProtKB | ||
| G | HLA-B | major histocompatibility complex, class I, B |
|
NAS | 6 | 31,321,649 | 31,324,989 | RGD:2290271 | UniProtKB | ||
| G | HLA-B | major histocompatibility complex, class I, B |
|
IEA | 6 | 31,321,649 | 31,324,989 | RGD:2290271 | InterPro | ||
| G | HLA-B | major histocompatibility complex, class I, B |
|
IEA | 6 | 31,321,649 | 31,324,989 | RGD:2290271 | InterPro | ||
| G | HLA-C | major histocompatibility complex, class I, C |
|
NAS | 6 | 31,236,526 | 31,239,913 | RGD:2290271 | UniProtKB | ||
| G | HLA-C | major histocompatibility complex, class I, C |
|
NAS | 6 | 31,236,526 | 31,239,913 | RGD:2290271 | UniProtKB | ||
| G | HLA-C | major histocompatibility complex, class I, C |
|
NAS | 6 | 31,236,526 | 31,239,913 | RGD:2290271 | UniProtKB | ||
| G | HLA-C | major histocompatibility complex, class I, C |
|
NAS | 6 | 31,236,526 | 31,239,913 | RGD:2290271 | UniProtKB | ||
| G | HLA-C | major histocompatibility complex, class I, C |
|
IEA | 6 | 31,236,526 | 31,239,913 | RGD:2290271 | InterPro | ||
| G | HLA-C | major histocompatibility complex, class I, C |
|
IEA | 6 | 31,236,526 | 31,239,913 | RGD:2290271 | InterPro | ||
| G | HLA-DMA | major histocompatibility complex, class II, DM alpha |
|
IEA | 6 | 32,916,391 | 32,920,899 | RGD:2290271 | InterPro | ||
| G | HLA-DMB | major histocompatibility complex, class II, DM beta |
|
IEA | 6 | 32,902,406 | 32,908,847 | RGD:2290271 | InterPro | ||
| G | HLA-DOA | major histocompatibility complex, class II, DO alpha |
|
IEA | 6 | 32,971,959 | 32,977,389 | RGD:2290271 | InterPro | ||
| G | HLA-DOB | major histocompatibility complex, class II, DO beta |
|
IEA | 6 | 32,780,540 | 32,784,825 | RGD:2290271 | InterPro | ||
| G | HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 |
|
NAS | 6 | 33,032,346 | 33,048,555 | RGD:2290271 | UniProtKB | ||
| G | HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 |
|
IEA | 6 | 33,032,346 | 33,048,555 | RGD:2290271 | InterPro | ||
| G | HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 |
|
IEA | 6 | 33,043,703 | 33,057,473 | RGD:2290271 | InterPro | ||
| G | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
|
NAS | 6 | 32,605,183 | 32,611,429 | RGD:2290271 | UniProtKB | ||
| G | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
|
NAS | 6 | 32,605,183 | 32,611,429 | RGD:2290271 | UniProtKB | ||
| G | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
|
IEA | 6 | 32,605,183 | 32,611,429 | RGD:2290271 | InterPro | ||
| G | HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 |
|
NAS | 6 | 32,709,163 | 32,714,664 | RGD:2290271 | UniProtKB | ||
| G | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
|
NAS | 6 | 32,627,241 | 32,634,466 | RGD:2290271 | UniProtKB | ||
| G | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
|
IEA | 6 | 32,627,241 | 32,634,466 | RGD:2290271 | InterPro | ||
| G | HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 |
|
NAS | 6 | 32,723,875 | 32,731,330 | RGD:2290271 | UniProtKB | ||
| G | HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 |
|
IEA | 6 | 32,723,875 | 32,731,330 | RGD:2290271 | InterPro | ||
| G | HLA-DRA | major histocompatibility complex, class II, DR alpha |
|
NAS | 6 | 32,407,619 | 32,412,823 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRA | major histocompatibility complex, class II, DR alpha |
|
NAS | 6 | 32,407,619 | 32,412,823 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRA | major histocompatibility complex, class II, DR alpha |
|
IEA | 6 | 32,407,619 | 32,412,823 | RGD:2290271 | InterPro | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
NAS | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
ISS | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
NAS | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
IMP | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
TAS | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
IDA | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
IDA | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 | TAS | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 | IDA | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 | IDA | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 | IMP | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | ISS | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 |
|
ISS | 6 | 32,485,151 | 32,498,006 | RGD:2290271 | UniProtKB | ||
| G | HLA-E | major histocompatibility complex, class I, E |
|
IEA | 6 | 30,457,183 | 30,461,982 | RGD:2290271 | InterPro | ||
| G | HLA-F | major histocompatibility complex, class I, F |
|
IEA | 6 | 29,691,117 | 29,695,073 | RGD:2290271 | InterPro | ||
| G | HLA-G | major histocompatibility complex, class I, G |
|
IEA | 6 | 29,794,756 | 29,798,899 | RGD:2290271 | InterPro | ||
| G | HLA-H | major histocompatibility complex, class I, H (pseudogene) |
|
NAS | 6 | 29,855,383 | 29,858,856 | RGD:2290271 | UniProtKB | ||
| G | HRH2 | histamine receptor H2 |
|
TAS | 5 | 175,085,040 | 175,113,245 | RGD:2290271 | PINC | ||
| G | ICOS | inducible T-cell co-stimulator |
|
NAS | 2 | 204,801,471 | 204,826,300 | RGD:2290271 | UniProtKB | ||
| G | IFI35 | interferon-induced protein 35 |
|
NAS | 17 | 41,158,742 | 41,166,476 | RGD:2290271 | UniProtKB | ||
| G | IFI44L | interferon-induced protein 44-like |
|
IEA | 1 | 79,086,088 | 79,111,830 | RGD:2290271 | ENSEMBL | ||
| G | IFI6 | interferon, alpha-inducible protein 6 |
|
TAS | 1 | 27,992,572 | 27,998,724 | RGD:2290271 | PINC | ||
| G | IFITM2 | interferon induced transmembrane protein 2 |
|
TAS | 11 | 308,107 | 309,410 | RGD:2290271 | PINC | ||
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
TAS | 11 | 319,673 | 320,914 | RGD:2290271 | PINC | ||
| G | IGF1R | insulin-like growth factor 1 receptor |
|
IMP | 15 | 99,192,761 | 99,507,759 | RGD:2290271 | BHF-UCL | ||
| G | IGHA1 | immunoglobulin heavy constant alpha 1 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGHA2 | immunoglobulin heavy constant alpha 2 (A2m marker) | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGHD | immunoglobulin heavy constant delta | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGHE | immunoglobulin heavy chain (epsilon polypeptide) | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGHG1 | immunoglobulin heavy constant gamma 1 (G1m marker) | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGHG2 | immunoglobulin heavy constant gamma 2 (G2m marker) | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGHG3 | immunoglobulin heavy constant gamma 3 (G3m marker) | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGHG4 | immunoglobulin heavy constant gamma 4 (G4m marker) | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGHM | immunoglobulin heavy constant mu | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGHV1OR15-1 | immunoglobulin heavy variable 1/OR15-1 (non-functional) |
|
NAS | 15 | 22,448,240 | 22,448,875 | RGD:2290271 | UniProtKB | ||
| G | IGHV@ | immunoglobulin heavy variable group | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGJ | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
|
NAS | 4 | 71,521,258 | 71,532,348 | RGD:2290271 | UniProtKB | ||
| G | IGKC | immunoglobulin kappa constant | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGKV1-5 | immunoglobulin kappa variable 1-5 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGKV4-1 | immunoglobulin kappa variable 4-1 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGLC1 | immunoglobulin lambda constant 1 (Mcg marker) | NAS | RGD:2290271 | UniProtKB | ||||||
| G | IGLL1 | immunoglobulin lambda-like polypeptide 1 |
|
NAS | 22 | 23,915,312 | 23,922,495 | RGD:2290271 | UniProtKB | ||
| G | IGSF6 | immunoglobulin superfamily, member 6 |
|
TAS | 16 | 21,652,605 | 21,663,987 | RGD:2290271 | PINC | ||
| G | IK | IK cytokine, down-regulator of HLA II |
|
TAS | 5 | 140,027,384 | 140,042,065 | RGD:2290271 | PINC | ||
| G | IKBKAP | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein |
|
TAS | 9 | 111,629,800 | 111,696,608 | RGD:2290271 | PINC | ||
| G | IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
|
NAS | 1 | 206,643,586 | 206,670,223 | RGD:2290271 | UniProtKB | ||
| G | IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
TAS | X | 153,770,459 | 153,793,261 | RGD:2290271 | PINC | ||
| G | IL10RB | interleukin 10 receptor, beta |
|
TAS | 21 | 34,638,665 | 34,669,539 | RGD:2290271 | PINC | ||
| G | IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
|
TAS | 3 | 159,706,623 | 159,713,806 | RGD:2290271 | UniProtKB | ||
| G | IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
|
IEA | 3 | 159,706,623 | 159,713,806 | RGD:2290271 | InterPro | ||
| G | IL13 | interleukin 13 |
|
IEA | 5 | 131,993,865 | 131,996,801 | RGD:2290271 | InterPro | ||
| G | IL15 | interleukin 15 |
|
IEA | 4 | 142,557,749 | 142,655,140 | RGD:2290271 | InterPro | ||
| G | IL16 | interleukin 16 |
|
TAS | 15 | 81,489,219 | 81,605,104 | RGD:2290271 | PINC | ||
| G | IL17A | interleukin 17A |
|
TAS | 6 | 52,051,185 | 52,055,436 | RGD:2290271 | PINC | ||
| G | IL17B | interleukin 17B |
|
TAS | 5 | 148,753,830 | 148,758,838 | RGD:2290271 | PINC | ||
| G | IL18 | interleukin 18 (interferon-gamma-inducing factor) |
|
TAS | 11 | 112,013,974 | 112,034,840 | RGD:2290271 | PINC | ||
| G | IL18R1 | interleukin 18 receptor 1 |
|
TAS | 2 | 102,979,097 | 103,015,218 | RGD:2290271 | PINC | ||
| G | IL18RAP | interleukin 18 receptor accessory protein |
|
TAS | 2 | 103,035,254 | 103,069,025 | RGD:2290271 | PINC | ||
| G | IL19 | interleukin 19 |
|
NAS | 1 | 206,972,215 | 207,016,326 | RGD:2290271 | UniProtKB | ||
| G | IL1A | interleukin 1, alpha |
|
IEA | 2 | 113,531,492 | 113,542,971 | RGD:2290271 | InterPro | ||
| G | IL1B | interleukin 1, beta |
|
IEA | 2 | 113,587,337 | 113,594,356 | RGD:2290271 | InterPro | ||
| G | IL1B | interleukin 1, beta |
|
IEA | 2 | 113,587,337 | 113,594,356 | RGD:2290271 | InterPro | ||
| G | IL1F10 | interleukin 1 family, member 10 (theta) |
|
IEA | 2 | 113,825,547 | 113,833,427 | RGD:2290271 | InterPro | ||
| G | IL1R1 | interleukin 1 receptor, type I |
|
TAS | 2 | 102,770,402 | 102,796,334 | RGD:2290271 | PINC | ||
| G | IL1R2 | interleukin 1 receptor, type II |
|
TAS | 2 | 102,608,306 | 102,644,885 | RGD:2290271 | PINC | ||
| G | IL1RAP | interleukin 1 receptor accessory protein |
|
TAS | 3 | 190,231,840 | 190,374,986 | RGD:2290271 | PINC | ||
| G | IL1RL1 | interleukin 1 receptor-like 1 |
|
NAS | 2 | 102,927,962 | 102,968,497 | RGD:2290271 | UniProtKB | ||
| G | IL1RN | interleukin 1 receptor antagonist |
|
NAS | 2 | 113,875,470 | 113,891,593 | RGD:2290271 | UniProtKB | ||
| G | IL2 | interleukin 2 |
|
TAS | 4 | 123,372,625 | 123,377,650 | RGD:2290271 | UniProtKB | ||
| G | IL21 | interleukin 21 |
|
IEA | 4 | 123,533,783 | 123,542,212 | RGD:2290271 | InterPro | ||
| G | IL27RA | interleukin 27 receptor, alpha |
|
TAS | 19 | 14,142,552 | 14,163,731 | RGD:2290271 | PINC | ||
| G | IL2RA | interleukin 2 receptor, alpha |
|
TAS | 10 | 6,052,657 | 6,104,333 | RGD:2290271 | PINC | ||
| G | IL2RG | interleukin 2 receptor, gamma |
|
TAS | X | 70,327,254 | 70,331,481 | RGD:2290271 | PINC | ||
| G | IL3 | interleukin 3 (colony-stimulating factor, multiple) |
|
IEA | 5 | 131,396,347 | 131,398,896 | RGD:2290271 | InterPro | ||
| G | IL32 | interleukin 32 |
|
TAS | 16 | 3,115,313 | 3,119,668 | RGD:2290271 | PINC | ||
| G | IL36A | interleukin 36, alpha |
|
NAS | 2 | 113,763,449 | 113,765,621 | RGD:2290271 | UniProtKB | ||
| G | IL36B | interleukin 36, beta |
|
NAS | 2 | 113,779,668 | 113,810,440 | RGD:2290271 | UniProtKB | ||
| G | IL37 | interleukin 37 |
|
NAS | 2 | 113,670,548 | 113,676,459 | RGD:2290271 | UniProtKB | ||
| G | IL37 | interleukin 37 |
|
NAS | 2 | 113,670,548 | 113,676,459 | RGD:2290271 | UniProtKB | ||
| G | IL4 | interleukin 4 |
|
TAS | 5 | 132,009,678 | 132,018,370 | RGD:2290271 | PINC | ||
| G | IL4R | interleukin 4 receptor |
|
TAS | 16 | 27,325,230 | 27,376,099 | RGD:2290271 | PINC | ||
| G | IL5 | interleukin 5 (colony-stimulating factor, eosinophil) |
|
IEA | 5 | 131,877,136 | 131,879,214 | RGD:2290271 | InterPro | ||
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
IEA | 7 | 22,766,766 | 22,771,621 | RGD:2290271 | InterPro | ||
| G | IL7 | interleukin 7 |
|
IEA | 8 | 79,645,007 | 79,717,758 | RGD:2290271 | InterPro | ||
| G | IL7 | interleukin 7 |
|
IEA | 8 | 79,645,007 | 79,717,758 | RGD:2290271 | InterPro | ||
| G | IL7R | interleukin 7 receptor |
|
TAS | 5 | 35,856,977 | 35,879,705 | RGD:2290271 | PINC | ||
| G | IL8 | interleukin 8 |
|
IEA | 4 | 74,606,223 | 74,609,433 | RGD:2290271 | InterPro | ||
| G | IL9 | interleukin 9 |
|
IEA | 5 | 135,227,935 | 135,231,516 | RGD:2290271 | InterPro | ||
| G | ILF2 | interleukin enhancer binding factor 2 |
|
IEA | 1 | 153,634,264 | 153,643,504 | RGD:2290271 | InterPro | ||
| G | IRF8 | interferon regulatory factor 8 |
|
TAS | 16 | 85,932,774 | 85,956,212 | RGD:2290271 | PINC | ||
| G | IRF8 | interferon regulatory factor 8 |
|
IEA | 16 | 85,932,774 | 85,956,212 | RGD:2290271 | ENSEMBL | ||
| G | ITGAD | integrin, alpha D |
|
NAS | 16 | 31,404,633 | 31,437,826 | RGD:2290271 | UniProtKB | ||
| G | KAAG1 | kidney associated antigen 1 |
|
NAS | 6 | 24,357,131 | 24,358,512 | RGD:2290271 | UniProtKB | ||
| G | KIR2DL1 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 |
|
TAS | 19 | 55,281,265 | 55,295,778 | RGD:2290271 | PINC | ||
| G | KIR2DL3 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 |
|
TAS | 19 | 55,249,974 | 55,264,504 | RGD:2290271 | PINC | ||
| G | KIR2DS1 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | KIR2DS2 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | KIR2DS5 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | KIR3DL1 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 |
|
NAS | 19 | 55,327,893 | 55,342,233 | RGD:2290271 | UniProtKB | ||
| G | KIR3DL1 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 |
|
NAS | 19 | 55,327,893 | 55,342,233 | RGD:2290271 | UniProtKB | ||
| G | KIR3DS1 | killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | LAT | linker for activation of T cells |
|
IDA | 16 | 28,996,147 | 29,002,104 | RGD:2290271 | HGNC | ||
| G | LAX1 | lymphocyte transmembrane adaptor 1 |
|
IDA | 1 | 203,734,284 | 203,745,500 | RGD:2290271 | HGNC | ||
| G | LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
|
TAS | 5 | 169,675,088 | 169,724,822 | RGD:2290271 | PINC | ||
| G | LIF | leukemia inhibitory factor |
|
IEA | 22 | 30,636,436 | 30,642,840 | RGD:2290271 | InterPro | ||
| G | LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
|
TAS | 19 | 54,777,675 | 54,785,033 | RGD:2290271 | PINC | ||
| G | LST1 | leukocyte specific transcript 1 |
|
NAS | 6 | 31,553,956 | 31,556,686 | RGD:2290271 | UniProtKB | ||
| G | LST1 | leukocyte specific transcript 1 |
|
NAS | 6 | 31,553,956 | 31,556,686 | RGD:2290271 | UniProtKB | ||
| G | LST1 | leukocyte specific transcript 1 |
|
IEA | 6 | 31,553,956 | 31,556,686 | RGD:2290271 | InterPro | ||
| G | LTB | lymphotoxin beta (TNF superfamily, member 3) |
|
IEA | 6 | 31,548,335 | 31,550,202 | RGD:2290271 | InterPro | ||
| G | LTB4R | leukotriene B4 receptor |
|
TAS | 14 | 24,780,705 | 24,787,242 | RGD:2290271 | PINC | ||
| G | LY75 | lymphocyte antigen 75 |
|
TAS | 2 | 160,659,866 | 160,761,267 | RGD:2290271 | PINC | ||
| G | LY75-CD302 | LY75-CD302 readthrough |
|
TAS | 2 | 160,625,139 | 160,761,267 | RGD:2290271 | PINC | ||
| G | MADCAM1 | mucosal vascular addressin cell adhesion molecule 1 |
|
TAS | 19 | 496,490 | 505,343 | RGD:2290271 | PINC | ||
| G | MAP3K14 | mitogen-activated protein kinase kinase kinase 14 |
|
ISS | 17 | 43,340,488 | 43,394,414 | RGD:2290271 | UniProtKB | ||
| G | MAP4K2 | mitogen-activated protein kinase kinase kinase kinase 2 |
|
TAS | 11 | 64,556,609 | 64,570,713 | RGD:2290271 | PINC | ||
| G | MARCH1 | membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
|
IDA | 4 | 164,445,450 | 165,304,407 | RGD:2290271 | UniProtKB | ||
| G | MARCH1 | membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
|
IDA | 4 | 164,445,450 | 165,304,407 | RGD:2290271 | UniProtKB | ||
| G | MARCH1 | membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
|
IEA | 4 | 164,445,450 | 165,304,407 | RGD:2290271 | ENSEMBL | ||
| G | MBP | myelin basic protein |
|
TAS | 18 | 74,690,789 | 74,844,774 | RGD:2290271 | PINC | ||
| G | MICA | MHC class I polypeptide-related sequence A |
|
IEA | 6 | 31,367,561 | 31,383,090 | RGD:2290271 | InterPro | ||
| G | MICB | MHC class I polypeptide-related sequence B |
|
IEA | 6 | 31,465,855 | 31,478,901 | RGD:2290271 | InterPro | ||
| G | MR1 | major histocompatibility complex, class I-related |
|
IEA | 1 | 181,002,561 | 181,031,074 | RGD:2290271 | InterPro | ||
| G | MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 |
|
TAS | 11 | 60,223,282 | 60,238,225 | RGD:2290271 | PINC | ||
| G | MYLPF | myosin light chain, phosphorylatable, fast skeletal muscle |
|
IEA | 16 | 30,386,123 | 30,389,310 | RGD:2290271 | ENSEMBL | ||
| G | NCF4 | neutrophil cytosolic factor 4, 40kDa |
|
TAS | 22 | 37,257,030 | 37,274,059 | RGD:2290271 | UniProtKB | ||
| G | NCR3 | natural cytotoxicity triggering receptor 3 |
|
NAS | 6 | 31,556,660 | 31,560,762 | RGD:2290271 | UniProtKB | ||
| G | NFIL3 | nuclear factor, interleukin 3 regulated |
|
TAS | 9 | 94,171,327 | 94,186,144 | RGD:2290271 | PINC | ||
| G | NOTCH1 | notch 1 |
|
NAS | 9 | 139,388,896 | 139,440,238 | RGD:2290271 | UniProtKB | ||
| G | OAS1 | 2'-5'-oligoadenylate synthetase 1, 40/46kDa |
|
IEA | 12 | 113,344,739 | 113,357,712 | RGD:2290271 | InterPro | ||
| G | OAS1 | 2'-5'-oligoadenylate synthetase 1, 40/46kDa |
|
IEA | 12 | 113,344,739 | 113,357,712 | RGD:2290271 | InterPro | ||
| G | OAS1 | 2'-5'-oligoadenylate synthetase 1, 40/46kDa |
|
IEA | 12 | 113,344,739 | 113,357,712 | RGD:2290271 | InterPro | ||
| G | OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa |
|
IEA | 12 | 113,416,274 | 113,449,528 | RGD:2290271 | InterPro | ||
| G | OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa |
|
IEA | 12 | 113,416,274 | 113,449,528 | RGD:2290271 | InterPro | ||
| G | OAS3 | 2'-5'-oligoadenylate synthetase 3, 100kDa |
|
IEA | 12 | 113,376,249 | 113,411,054 | RGD:2290271 | InterPro | ||
| G | OAS3 | 2'-5'-oligoadenylate synthetase 3, 100kDa |
|
IEA | 12 | 113,376,249 | 113,411,054 | RGD:2290271 | InterPro | ||
| G | OPRD1 | opioid receptor, delta 1 |
|
TAS | 1 | 29,138,654 | 29,190,208 | RGD:2290271 | PINC | ||
| G | OPRK1 | opioid receptor, kappa 1 |
|
IDA | 8 | 54,138,276 | 54,164,194 | RGD:2290271 | UniProtKB | ||
| G | OSM | oncostatin M |
|
IEA | 22 | 30,658,818 | 30,662,829 | RGD:2290271 | InterPro | ||
| G | PDCD1LG2 | programmed cell death 1 ligand 2 |
|
NAS | 9 | 5,510,545 | 5,571,282 | RGD:2290271 | UniProtKB | ||
| G | PF4 | platelet factor 4 |
|
IEA | 4 | 74,846,542 | 74,847,841 | RGD:2290271 | InterPro | ||
| G | PF4V1 | platelet factor 4 variant 1 |
|
IEA | 4 | 74,719,013 | 74,720,198 | RGD:2290271 | InterPro | ||
| G | PGLYRP1 | peptidoglycan recognition protein 1 |
|
TAS | 19 | 46,522,411 | 46,526,556 | RGD:2290271 | PINC | ||
| G | PKHD1L1 | polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 |
|
NAS | 8 | 110,374,706 | 110,543,500 | RGD:2290271 | UniProtKB | ||
| G | PNP | purine nucleoside phosphorylase |
|
IMP | 14 | 20,937,538 | 20,946,165 | RGD:2290271 | UniProtKB | ||
| G | PRELID1 | PRELI domain containing 1 |
|
TAS | 5 | 176,730,835 | 176,733,950 | RGD:2290271 | PINC | ||
| G | PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) |
|
IEA | 11 | 57,154,834 | 57,158,130 | RGD:2290271 | InterPro | ||
| G | PRG3 | proteoglycan 3 |
|
IEA | 11 | 57,144,242 | 57,148,623 | RGD:2290271 | InterPro | ||
| G | PRG4 | proteoglycan 4 |
|
IEA | 1 | 186,265,405 | 186,283,688 | RGD:2290271 | InterPro | ||
| G | PRKRA | protein kinase, interferon-inducible double stranded RNA dependent activator |
|
TAS | 2 | 179,296,141 | 179,315,958 | RGD:2290271 | PINC | ||
| G | PROCR | protein C receptor, endothelial |
|
IEA | 20 | 33,759,774 | 33,765,165 | RGD:2290271 | InterPro | ||
| G | PTAFR | platelet-activating factor receptor |
|
TAS | 1 | 28,473,677 | 28,520,447 | RGD:2290271 | PINC | ||
| G | PTGDR2 | prostaglandin D2 receptor 2 |
|
TAS | 11 | 60,618,398 | 60,623,444 | RGD:2290271 | PINC | ||
| G | PTGER4 | prostaglandin E receptor 4 (subtype EP4) |
|
IEP | 5 | 40,680,032 | 40,693,837 | RGD:2290271 | UniProtKB | ||
| G | PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) |
|
NAS | 11 | 119,508,808 | 119,599,435 | RGD:2290271 | UniProtKB | ||
| G | PXDN | peroxidasin homolog (Drosophila) |
|
NAS | 2 | 1,635,659 | 1,748,291 | RGD:2290271 | UniProtKB | ||
| G | RAET1E | retinoic acid early transcript 1E |
|
IEA | 6 | 150,204,511 | 150,217,195 | RGD:2290271 | InterPro | ||
| G | RAET1G | retinoic acid early transcript 1G |
|
IEA | 6 | 150,238,014 | 150,244,214 | RGD:2290271 | InterPro | ||
| G | RAET1L | retinoic acid early transcript 1L |
|
IEA | 6 | 150,341,266 | 150,346,668 | RGD:2290271 | InterPro | ||
| G | RAG1 | recombination activating gene 1 |
|
TAS | 11 | 36,589,563 | 36,601,312 | RGD:2290271 | PINC | ||
| G | RFX1 | regulatory factor X, 1 (influences HLA class II expression) |
|
TAS | 19 | 14,072,342 | 14,117,134 | RGD:2290271 | PINC | ||
| G | RGS1 | regulator of G-protein signaling 1 |
|
TAS | 1 | 192,544,857 | 192,549,159 | RGD:2290271 | PINC | ||
| G | S1PR4 | sphingosine-1-phosphate receptor 4 |
|
TAS | 19 | 3,178,736 | 3,180,330 | RGD:2290271 | PINC | ||
| G | SAMHD1 | SAM domain and HD domain 1 |
|
NAS | 20 | 35,520,227 | 35,580,246 | RGD:2290271 | UniProtKB | ||
| G | SBSPON | somatomedin B and thrombospondin, type 1 domain containing |
|
IEA | 8 | 73,976,778 | 74,005,507 | RGD:2290271 | InterPro | ||
| G | SECTM1 | secreted and transmembrane 1 |
|
TAS | 17 | 80,278,900 | 80,291,921 | RGD:2290271 | PINC | ||
| G | SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
|
TAS | 7 | 80,371,854 | 80,548,667 | RGD:2290271 | PINC | ||
| G | SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
|
TAS | 9 | 91,975,706 | 92,094,611 | RGD:2290271 | PINC | ||
| G | SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
|
TAS | 15 | 74,701,630 | 74,726,299 | RGD:2290271 | PINC | ||
| G | SERPINB4 | serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
|
NAS | 18 | 61,304,493 | 61,311,502 | RGD:2290271 | UniProtKB | ||
| G | SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
|
IDA | 6 | 2,887,499 | 2,903,546 | RGD:2290271 | UniProtKB | ||
| G | SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
|
NAS | 2 | 219,246,752 | 219,261,617 | RGD:2290271 | UniProtKB | ||
| G | SMAD3 | SMAD family member 3 |
|
IMP | 15 | 67,358,195 | 67,487,533 | RGD:2290271 | BHF-UCL | ||
| G | SMAD6 | SMAD family member 6 |
|
IMP | 15 | 66,994,674 | 67,074,338 | RGD:2290271 | BHF-UCL | ||
| G | SP2 | Sp2 transcription factor |
|
TAS | 17 | 45,973,516 | 46,006,323 | RGD:2290271 | PINC | ||
| G | SPN | sialophorin |
|
TAS | 16 | 29,674,271 | 29,681,828 | RGD:2290271 | PINC | ||
| G | SUSD2 | sushi domain containing 2 |
|
IEA | 22 | 24,577,444 | 24,585,074 | RGD:2290271 | InterPro | ||
| G | TAPBP | TAP binding protein (tapasin) |
|
TAS | 6 | 33,267,471 | 33,282,164 | RGD:2290271 | PINC | ||
| G | TCF12 | transcription factor 12 |
|
TAS | 15 | 57,210,833 | 57,580,716 | RGD:2290271 | PINC | ||
| G | TCF7 | transcription factor 7 (T-cell specific, HMG-box) |
|
TAS | 5 | 133,450,402 | 133,483,920 | RGD:2290271 | PINC | ||
| G | TENM1 | teneurin transmembrane protein 1 |
|
TAS | X | 123,509,753 | 124,097,666 | RGD:2290271 | PINC | ||
| G | TGFBR3 | transforming growth factor, beta receptor III |
|
IMP | 1 | 92,145,900 | 92,371,559 | RGD:2290271 | BHF-UCL | ||
| G | THBS1 | thrombospondin 1 |
|
IEP | 15 | 39,873,280 | 39,889,668 | RGD:2290271 | BHF-UCL | ||
| G | TINAG | tubulointerstitial nephritis antigen |
|
IEA | 6 | 54,173,203 | 54,254,950 | RGD:2290271 | InterPro | ||
| G | TINAGL1 | tubulointerstitial nephritis antigen-like 1 |
|
IEA | 1 | 32,042,086 | 32,053,287 | RGD:2290271 | InterPro | ||
| G | TLR1 | toll-like receptor 1 |
|
TAS | 4 | 38,797,876 | 38,806,412 | RGD:2290271 | PINC | ||
| G | TLR10 | toll-like receptor 10 |
|
NAS | 4 | 38,773,860 | 38,784,611 | RGD:2290271 | UniProtKB | ||
| G | TLR2 | toll-like receptor 2 |
|
TAS | 4 | 154,605,441 | 154,627,243 | RGD:2290271 | PINC | ||
| G | TLR4 | toll-like receptor 4 |
|
TAS | 9 | 120,466,453 | 120,479,769 | RGD:2290271 | PINC | ||
| G | TLR6 | toll-like receptor 6 |
|
TAS | 4 | 38,825,325 | 38,858,438 | RGD:2290271 | PINC | ||
| G | TNFAIP1 | tumor necrosis factor, alpha-induced protein 1 (endothelial) |
|
IEP | 17 | 26,662,548 | 26,674,035 | RGD:2290271 | UniProtKB | ||
| G | TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 |
|
TAS | 1 | 2,487,805 | 2,495,268 | RGD:2290271 | PINC | ||
| G | TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B |
|
IEA | 1 | 12,227,060 | 12,269,277 | RGD:2290271 | ENSEMBL | ||
| G | TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 |
|
TAS | 1 | 1,146,706 | 1,149,548 | RGD:2290271 | PINC | ||
| G | TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 |
|
IEA | 3 | 172,223,298 | 172,241,297 | RGD:2290271 | InterPro | ||
| G | TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 |
|
NAS | 13 | 43,136,872 | 43,182,149 | RGD:2290271 | UniProtKB | ||
| G | TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 |
|
IEA | 17 | 7,452,375 | 7,461,207 | RGD:2290271 | InterPro | ||
| G | TNFSF12-TNFSF13 | TNFSF12-TNFSF13 readthrough |
|
IEA | 17 | 7,452,375 | 7,464,925 | RGD:2290271 | InterPro | ||
| G | TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 |
|
IEA | 17 | 7,461,609 | 7,464,925 | RGD:2290271 | InterPro | ||
| G | TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b |
|
IEA | 13 | 108,921,977 | 108,960,832 | RGD:2290271 | InterPro | ||
| G | TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 |
|
IEA | 19 | 6,663,148 | 6,670,599 | RGD:2290271 | InterPro | ||
| G | TNFSF15 | tumor necrosis factor (ligand) superfamily, member 15 |
|
IEA | 9 | 117,546,915 | 117,568,408 | RGD:2290271 | InterPro | ||
| G | TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
|
IEA | 1 | 173,152,870 | 173,176,471 | RGD:2290271 | InterPro | ||
| G | TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 |
|
IEA | 9 | 117,655,623 | 117,692,875 | RGD:2290271 | InterPro | ||
| G | TNFSF9 | tumor necrosis factor (ligand) superfamily, member 9 |
|
IEA | 19 | 6,531,010 | 6,535,939 | RGD:2290271 | InterPro | ||
| G | TRB | T cell receptor beta locus |
|
NAS | 7 | 141,998,851 | 142,510,972 | RGD:2290271 | UniProtKB | ||
| G | TRBC1 | T cell receptor beta constant 1 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | TRBV12-3 | T cell receptor beta variable 12-3 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | TRGC2 | T cell receptor gamma constant 2 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | TRGV3 | T cell receptor gamma variable 3 | NAS | RGD:2290271 | UniProtKB | ||||||
| G | TRIM22 | tripartite motif containing 22 |
|
TAS | 11 | 5,710,817 | 5,732,093 | RGD:2290271 | PINC | ||
| G | VIPR1 | vasoactive intestinal peptide receptor 1 |
|
TAS | 3 | 42,530,791 | 42,579,065 | RGD:2290271 | PINC | ||
| G | VPREB1 | pre-B lymphocyte 1 |
|
NAS | 22 | 22,599,200 | 22,599,926 | RGD:2290271 | UniProtKB | ||
| G | VTN | vitronectin |
|
IEA | 17 | 26,694,298 | 26,697,373 | RGD:2290271 | InterPro | ||
| G | WAS | Wiskott-Aldrich syndrome |
|
IMP | X | 48,542,186 | 48,549,818 | RGD:2290271 | HGNC | ||
| G | XBP1 | X-box binding protein 1 |
|
TAS | 22 | 29,190,548 | 29,196,560 | RGD:2290271 | PINC | ||
| G | XCL1 | chemokine (C motif) ligand 1 |
|
IEA | 1 | 168,545,711 | 168,551,315 | RGD:2290271 | InterPro | ||
| G | XCL2 | chemokine (C motif) ligand 2 |
|
IEA | 1 | 168,510,003 | 168,513,235 | RGD:2290271 | InterPro | ||
| G | ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa |
|
IDA | 2 | 98,330,031 | 98,356,323 | RGD:2290271 | UniProtKB | ||
| G | ZEB1 | zinc finger E-box binding homeobox 1 |
|
TAS | 10 | 31,608,101 | 31,818,742 | RGD:2290271 | PINC | ||
acute inflammatory response to antigenic stimulus
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | NPFF | neuropeptide FF-amide peptide precursor |
|
IEA | 12 | 53,900,474 | 53,901,422 | RGD:2290271 | ENSEMBL | ||
adaptive immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL10 | B-cell CLL/lymphoma 10 |
|
TAS | 1 | 85,731,459 | 85,742,587 | RGD:2290271 | UniProtKB | ||
| G | BTK | Bruton agammaglobulinemia tyrosine kinase |
|
TAS | X | 100,604,435 | 100,641,212 | RGD:2290271 | UniProtKB | ||
| G | CTSH | cathepsin H |
|
IEP | 15 | 79,214,092 | 79,237,420 | RGD:2290271 | UniProtKB | ||
| G | CTSL1 | cathepsin L1 |
|
IEP | 9 | 90,340,974 | 90,346,384 | RGD:2290271 | UniProtKB | ||
| G | CTSS | cathepsin S |
|
IEP | 1 | 150,702,672 | 150,738,433 | RGD:2290271 | UniProtKB | ||
| G | IFNB1 | interferon, beta 1, fibroblast |
|
IEA | 9 | 21,077,104 | 21,077,943 | RGD:2290271 | ENSEMBL | ||
| G | IFNG | interferon, gamma |
|
IEA | 12 | 68,548,550 | 68,553,521 | RGD:2290271 | ENSEMBL | ||
| G | ITK | IL2-inducible T-cell kinase |
|
ISS | 5 | 156,607,907 | 156,682,109 | RGD:2290271 | UniProtKB | ||
| G | JAM3 | junctional adhesion molecule 3 |
|
IEA | 11 | 133,938,820 | 134,021,652 | RGD:2290271 | ENSEMBL | ||
| G | NEDD4 | neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
|
IEA | 15 | 56,119,120 | 56,285,835 | RGD:2290271 | ENSEMBL | ||
| G | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
TAS | 1 | 9,711,790 | 9,789,172 | RGD:2290271 | UniProtKB | ||
| G | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
TAS | 7 | 106,505,924 | 106,547,592 | RGD:2290271 | UniProtKB | ||
| G | RIPK2 | receptor-interacting serine-threonine kinase 2 |
|
ISS | 8 | 90,769,975 | 90,803,292 | RGD:2290271 | UniProtKB | ||
| G | SYK | spleen tyrosine kinase |
|
ISS | 9 | 93,564,012 | 93,660,842 | RGD:2290271 | UniProtKB | ||
| G | TNFRSF11A | tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
|
IMP | 18 | 59,992,520 | 60,054,943 | RGD:2290271 | BHF-UCL | ||
| G | TXK | TXK tyrosine kinase |
|
ISS | 4 | 48,068,410 | 48,136,273 | RGD:2290271 | UniProtKB | ||
| G | ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa |
|
TAS | 2 | 98,330,031 | 98,356,323 | RGD:2290271 | UniProtKB | ||
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | TGFB1 | transforming growth factor, beta 1 |
|
IEA | 19 | 41,836,812 | 41,859,831 | RGD:2290271 | ENSEMBL | ||
antigen transcytosis by M cells in mucosal-associated lymphoid tissue
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GP2 | glycoprotein 2 (zymogen granule membrane) |
|
IEA | 16 | 20,321,811 | 20,338,835 | RGD:2290271 | ENSEMBL | ||
B cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | HSPD1 | heat shock 60kDa protein 1 (chaperonin) |
|
IDA | 2 | 198,351,308 | 198,364,998 | RGD:2290271 | BHF-UCL | ||
B cell mediated immunity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FAS | Fas (TNF receptor superfamily, member 6) |
|
IEA | 10 | 90,750,288 | 90,775,542 | RGD:2290271 | ENSEMBL | ||
| G | MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
|
ISS | 2 | 47,630,206 | 47,710,367 | RGD:2290271 | BHF-UCL | ||
| G | SLA2 | Src-like-adaptor 2 |
|
TAS | 20 | 35,240,922 | 35,274,619 | RGD:2290271 | UniProtKB | ||
basophil degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | PI4K2A | phosphatidylinositol 4-kinase type 2 alpha |
|
IEA | 10 | 99,400,443 | 99,436,187 | RGD:2290271 | ENSEMBL | ||
CD8-positive, alpha-beta T cell differentiation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | EOMES | eomesodermin |
|
IMP | 3 | 27,757,868 | 27,763,785 | RGD:2290271 | UniProtKB | ||
| G | IFNG | interferon, gamma |
|
IEA | 12 | 68,548,550 | 68,553,521 | RGD:2290271 | ENSEMBL | ||
chronic inflammatory response to antigenic stimulus
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AHCY | adenosylhomocysteinase |
|
IEA | 20 | 32,868,071 | 32,899,608 | RGD:2290271 | ENSEMBL | ||
| G | IL1RN | interleukin 1 receptor antagonist |
|
IEA | 2 | 113,875,470 | 113,891,593 | RGD:2290271 | ENSEMBL | ||
| G | TNF | tumor necrosis factor |
|
IMP | 6 | 31,543,344 | 31,546,113 | RGD:2290271 | BHF-UCL | ||
complement activation, classical pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | C1QA | complement component 1, q subcomponent, A chain |
|
TAS | 1 | 22,963,118 | 22,966,175 | RGD:2290271 | Reactome | ||
| G | C1QB | complement component 1, q subcomponent, B chain |
|
TAS | 1 | 22,979,682 | 22,988,029 | RGD:2290271 | Reactome | ||
| G | C1QBP | complement component 1, q subcomponent binding protein |
|
IEA | 17 | 5,336,099 | 5,342,471 | RGD:2290271 | UniProtKB | ||
| G | C1QC | complement component 1, q subcomponent, C chain |
|
TAS | 1 | 22,970,118 | 22,974,603 | RGD:2290271 | Reactome | ||
| G | C1R | complement component 1, r subcomponent |
|
TAS | 12 12 |
7,241,205 7,187,513 |
7,245,043 7,189,412 |
RGD:2290271 | Reactome | ||
| G | C1RL | complement component 1, r subcomponent-like |
|
IEA | 12 | 7,247,146 | 7,261,869 | RGD:2290271 | UniProtKB | ||
| G | C1S | complement component 1, s subcomponent |
|
TAS | 12 | 7,167,980 | 7,178,336 | RGD:2290271 | Reactome | ||
| G | C2 | complement component 2 |
|
IEA | 6 | 31,865,562 | 31,913,449 | RGD:2290271 | UniProtKB | ||
| G | C3 | complement component 3 |
|
IEA | 19 | 6,677,846 | 6,720,662 | RGD:2290271 | UniProtKB | ||
| G | C4A | complement component 4A (Rodgers blood group) |
|
IEA | 6 | 31,949,834 | 31,970,457 | RGD:2290271 | UniProtKB | ||
| G | C4B | complement component 4B (Chido blood group) |
|
IEA | 6 | 31,982,572 | 32,003,195 | RGD:2290271 | UniProtKB | ||
| G | C4BPA | complement component 4 binding protein, alpha |
|
IEA | 1 | 207,277,607 | 207,318,317 | RGD:2290271 | UniProtKB | ||
| G | C4BPB | complement component 4 binding protein, beta |
|
IEA | 1 | 207,262,212 | 207,273,338 | RGD:2290271 | UniProtKB | ||
| G | C5 | complement component 5 |
|
IEA | 9 | 123,714,613 | 123,812,554 | RGD:2290271 | UniProtKB | ||
| G | C6 | complement component 6 |
|
IEA | 5 | 41,142,336 | 41,261,540 | RGD:2290271 | UniProtKB | ||
| G | C7 | complement component 7 |
|
IEA | 5 | 40,909,599 | 40,983,041 | RGD:2290271 | UniProtKB | ||
| G | C8A | complement component 8, alpha polypeptide |
|
IEA | 1 | 57,320,443 | 57,383,894 | RGD:2290271 | UniProtKB | ||
| G | C8B | complement component 8, beta polypeptide |
|
IEA | 1 | 57,394,883 | 57,431,688 | RGD:2290271 | UniProtKB | ||
| G | C8G | complement component 8, gamma polypeptide |
|
IEA | 9 | 139,839,698 | 139,841,426 | RGD:2290271 | UniProtKB | ||
| G | C9 | complement component 9 |
|
IEA | 5 | 39,284,377 | 39,364,655 | RGD:2290271 | UniProtKB | ||
| G | CD46 | CD46 molecule, complement regulatory protein |
|
IEA | 1 | 207,925,383 | 207,968,861 | RGD:2290271 | UniProtKB | ||
| G | CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
|
IEA | 1 | 207,494,817 | 207,534,311 | RGD:2290271 | UniProtKB | ||
| G | CFI | complement factor I |
|
IEA | 4 | 110,661,848 | 110,723,335 | RGD:2290271 | UniProtKB | ||
| G | CLU | clusterin |
|
IEA | 8 | 27,454,434 | 27,472,328 | RGD:2290271 | UniProtKB | ||
| G | CR1 | complement component (3b/4b) receptor 1 (Knops blood group) |
|
IEA | 1 | 207,669,473 | 207,815,110 | RGD:2290271 | UniProtKB | ||
| G | CR2 | complement component (3d/Epstein Barr virus) receptor 2 |
|
IEA | 1 | 207,627,645 | 207,663,240 | RGD:2290271 | UniProtKB | ||
| G | CRP | C-reactive protein, pentraxin-related |
|
IEA | 1 | 159,682,079 | 159,684,379 | RGD:2290271 | ENSEMBL | ||
| G | IGHG1 | immunoglobulin heavy constant gamma 1 (G1m marker) | TAS | RGD:2290271 | Reactome | ||||||
| G | IGHG2 | immunoglobulin heavy constant gamma 2 (G2m marker) | TAS | RGD:2290271 | Reactome | ||||||
| G | IGHG3 | immunoglobulin heavy constant gamma 3 (G3m marker) | TAS | RGD:2290271 | Reactome | ||||||
| G | IGHG4 | immunoglobulin heavy constant gamma 4 (G4m marker) | TAS | RGD:2290271 | Reactome | ||||||
| G | IGHV@ | immunoglobulin heavy variable group | TAS | RGD:2290271 | Reactome | ||||||
| G | IGKC | immunoglobulin kappa constant | TAS | RGD:2290271 | Reactome | ||||||
| G | IGKV1-5 | immunoglobulin kappa variable 1-5 | TAS | RGD:2290271 | Reactome | ||||||
| G | IGKV4-1 | immunoglobulin kappa variable 4-1 | TAS | RGD:2290271 | Reactome | ||||||
| G | IGLC1 | immunoglobulin lambda constant 1 (Mcg marker) | TAS | RGD:2290271 | Reactome | ||||||
| G | IGLC2 | immunoglobulin lambda constant 2 (Kern-Oz- marker) | TAS | RGD:2290271 | Reactome | ||||||
| G | IGLC3 | immunoglobulin lambda constant 3 (Kern-Oz+ marker) | TAS | RGD:2290271 | Reactome | ||||||
| G | IGLC6 | immunoglobulin lambda constant 6 (Kern+Oz- marker) | TAS | RGD:2290271 | Reactome | ||||||
| G | IGLC7 | immunoglobulin lambda constant 7 | TAS | RGD:2290271 | Reactome | ||||||
| G | MASP2 | mannan-binding lectin serine peptidase 2 |
|
IEA | 1 | 11,086,580 | 11,107,296 | RGD:2290271 | UniProtKB | ||
| G | MBL2 | mannose-binding lectin (protein C) 2, soluble |
|
IEA | 10 | 54,525,140 | 54,531,460 | RGD:2290271 | UniProtKB | ||
| G | SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
IEA | 11 | 57,365,027 | 57,382,326 | RGD:2290271 | UniProtKB | ||
cytokine production involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | NOD2 | nucleotide-binding oligomerization domain containing 2 |
|
IMP | 16 | 50,731,050 | 50,766,987 | RGD:2290271 | UniProtKB | ||
cytotoxic T cell degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | RAB27A | RAB27A, member RAS oncogene family |
|
IEA | 15 | 55,495,164 | 55,582,013 | RGD:2290271 | ENSEMBL | ||
dendritic cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
ISS | 4 | 55,524,095 | 55,606,881 | RGD:2290271 | UniProtKB | ||
eosinophil degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CCL3 | chemokine (C-C motif) ligand 3 |
|
IDA | 17 | 34,415,602 | 34,417,506 | RGD:2290271 | UniProtKB | ||
| G | VAMP7 | vesicle-associated membrane protein 7 |
|
ISS | X Y |
155,110,943 59,213,949 |
155,173,433 59,276,439 |
RGD:2290271 | UniProtKB | ||
follicular B cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) |
|
IEA | 16 | 81,812,899 | 81,991,899 | RGD:2290271 | ENSEMBL | ||
germinal center B cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADA | adenosine deaminase |
|
IEA | 20 | 43,248,163 | 43,280,376 | RGD:2290271 | ENSEMBL | ||
germinal center formation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADAM17 | ADAM metallopeptidase domain 17 |
|
ISS | 2 | 9,629,392 | 9,695,917 | RGD:2290271 | BHF-UCL | ||
| G | BCL3 | B-cell CLL/lymphoma 3 |
|
IEA | 19 | 45,251,978 | 45,263,301 | RGD:2290271 | ENSEMBL | ||
| G | BCL6 | B-cell CLL/lymphoma 6 |
|
IEA | 3 | 187,439,165 | 187,463,513 | RGD:2290271 | ENSEMBL | ||
| G | CXCL13 | chemokine (C-X-C motif) ligand 13 |
|
NAS | 4 | 78,432,907 | 78,532,988 | RGD:2290271 | BHF-UCL | ||
| G | KLHL6 | kelch-like family member 6 |
|
IEA | 3 | 183,205,319 | 183,273,499 | RGD:2290271 | ENSEMBL | ||
| G | MEF2A | myocyte enhancer factor 2A |
|
IEA | 15 | 100,106,133 | 100,256,630 | RGD:2290271 | ENSEMBL | ||
| G | MEF2C | myocyte enhancer factor 2C |
|
ISS | 5 | 88,014,058 | 88,199,922 | RGD:2290271 | UniProtKB | ||
| G | MEF2C | myocyte enhancer factor 2C |
|
IEA | 5 | 88,014,058 | 88,199,922 | RGD:2290271 | ENSEMBL | ||
| G | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
|
IEA | 10 | 104,153,867 | 104,162,286 | RGD:2290271 | ENSEMBL | ||
| G | UNC13D | unc-13 homolog D (C. elegans) |
|
IEA | 17 | 73,823,306 | 73,840,798 | RGD:2290271 | ENSEMBL | ||
helper T cell enhancement of adaptive immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | NLRP10 | NLR family, pyrin domain containing 10 |
|
ISS | 11 | 7,981,156 | 7,985,059 | RGD:2290271 | UniProtKB | ||
hepatic immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
TAS | 7 | 22,766,766 | 22,771,621 | RGD:2290271 | BHF-UCL | ||
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
IDA | 7 | 22,766,766 | 22,771,621 | RGD:2290271 | BHF-UCL | ||
| G | IL6R | interleukin 6 receptor |
|
TAS | 1 | 154,377,669 | 154,441,926 | RGD:2290271 | BHF-UCL | ||
histamine secretion by mast cell
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADORA3 | adenosine A3 receptor |
|
IEA | 1 | 112,025,970 | 112,106,597 | RGD:2290271 | ENSEMBL | ||
| G | LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
IEA | 8 | 56,792,386 | 56,925,006 | RGD:2290271 | ENSEMBL | ||
| G | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
IEA | 8 | 101,930,804 | 101,965,623 | RGD:2290271 | ENSEMBL | ||
humoral immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AIRE | autoimmune regulator |
|
IEA | 21 | 45,705,721 | 45,718,102 | RGD:2290271 | ENSEMBL | ||
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
TAS | 18 | 60,790,579 | 60,986,613 | RGD:2290271 | UniProtKB | ||
| G | BLNK | B-cell linker |
|
TAS | 10 | 97,951,455 | 98,031,333 | RGD:2290271 | PINC | ||
| G | BST1 | bone marrow stromal cell antigen 1 |
|
TAS | 4 | 15,704,573 | 15,733,796 | RGD:2290271 | PINC | ||
| G | BST2 | bone marrow stromal cell antigen 2 |
|
TAS | 19 | 17,513,755 | 17,516,384 | RGD:2290271 | PINC | ||
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
TAS | 17 | 32,582,296 | 32,584,222 | RGD:2290271 | PINC | ||
| G | CCR6 | chemokine (C-C motif) receptor 6 |
|
TAS | 6 | 167,525,295 | 167,552,629 | RGD:2290271 | PINC | ||
| G | CD28 | CD28 molecule |
|
TAS | 2 | 204,571,198 | 204,603,635 | RGD:2290271 | UniProtKB | ||
| G | CD83 | CD83 molecule |
|
TAS | 6 | 14,117,487 | 14,137,149 | RGD:2290271 | PINC | ||
| G | EBI3 | Epstein-Barr virus induced 3 |
|
TAS | 19 | 4,229,540 | 4,237,525 | RGD:2290271 | PINC | ||
| G | FOXJ1 | forkhead box J1 |
|
ISS | 17 | 74,132,414 | 74,137,380 | RGD:2290271 | BHF-UCL | ||
| G | GATA3 | GATA binding protein 3 |
|
IEA | 10 | 8,096,667 | 8,117,164 | RGD:2290271 | ENSEMBL | ||
| G | GPI | glucose-6-phosphate isomerase |
|
TAS | 19 | 34,855,645 | 34,893,318 | RGD:2290271 | PINC | ||
| G | GPR183 | G protein-coupled receptor 183 |
|
ISS | 13 | 99,946,789 | 99,959,749 | RGD:2290271 | UniProtKB | ||
| G | IFNB1 | interferon, beta 1, fibroblast |
|
IEA | 9 | 21,077,104 | 21,077,943 | RGD:2290271 | ENSEMBL | ||
| G | IFNG | interferon, gamma |
|
IEA | 12 | 68,548,550 | 68,553,521 | RGD:2290271 | ENSEMBL | ||
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
IC | 7 | 22,766,766 | 22,771,621 | RGD:2290271 | BHF-UCL | ||
| G | IL7 | interleukin 7 |
|
TAS | 8 | 79,645,007 | 79,717,758 | RGD:2290271 | PINC | ||
| G | LTA | lymphotoxin alpha (TNF superfamily, member 1) |
|
IEA | 6 | 31,539,876 | 31,542,101 | RGD:2290271 | ENSEMBL | ||
| G | LTF | lactotransferrin |
|
TAS | 3 | 46,477,496 | 46,506,598 | RGD:2290271 | PINC | ||
| G | LY86 | lymphocyte antigen 86 |
|
TAS | 6 | 6,588,934 | 6,655,216 | RGD:2290271 | PINC | ||
| G | MEF2A | myocyte enhancer factor 2A |
|
IEA | 15 | 100,106,133 | 100,256,630 | RGD:2290271 | ENSEMBL | ||
| G | MEF2C | myocyte enhancer factor 2C |
|
ISS | 5 | 88,014,058 | 88,199,922 | RGD:2290271 | UniProtKB | ||
| G | MEF2C | myocyte enhancer factor 2C |
|
IEA | 5 | 88,014,058 | 88,199,922 | RGD:2290271 | ENSEMBL | ||
| G | MNX1 | motor neuron and pancreas homeobox 1 |
|
TAS | 7 | 156,797,547 | 156,803,347 | RGD:2290271 | PINC | ||
| G | MS4A2 | membrane-spanning 4-domains, subfamily A, member 2 |
|
TAS | 11 | 59,856,137 | 59,865,940 | RGD:2290271 | PINC | ||
| G | NOTCH1 | notch 1 |
|
IEA | 9 | 139,388,896 | 139,440,238 | RGD:2290271 | ENSEMBL | ||
| G | NOTCH2 | notch 2 |
|
IEA | 1 | 120,454,176 | 120,612,317 | RGD:2290271 | ENSEMBL | ||
| G | PAX5 | paired box 5 |
|
TAS | 9 | 36,838,531 | 37,034,476 | RGD:2290271 | PINC | ||
| G | PDCD1 | programmed cell death 1 |
|
TAS | 2 | 242,792,033 | 242,801,058 | RGD:2290271 | PINC | ||
| G | POU2AF1 | POU class 2 associating factor 1 |
|
TAS | 11 | 111,222,980 | 111,250,157 | RGD:2290271 | PINC | ||
| G | POU2F2 | POU class 2 homeobox 2 |
|
TAS | 19 | 42,590,262 | 42,636,625 | RGD:2290271 | PINC | ||
| G | PSMB10 | proteasome (prosome, macropain) subunit, beta type, 10 |
|
TAS | 16 | 67,968,407 | 67,970,780 | RGD:2290271 | PINC | ||
| G | SH2D1A | SH2 domain containing 1A |
|
IEA | X | 123,480,132 | 123,507,010 | RGD:2290271 | ENSEMBL | ||
| G | ST6GAL1 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
TAS | 3 | 186,648,315 | 186,796,341 | RGD:2290271 | PINC | ||
| G | TFE3 | transcription factor binding to IGHM enhancer 3 |
|
ISS | X | 48,886,242 | 48,900,990 | RGD:2290271 | UniProtKB | ||
| G | TFEB | transcription factor EB |
|
ISS | 6 | 41,651,716 | 41,703,997 | RGD:2290271 | UniProtKB | ||
| G | TFEB | transcription factor EB |
|
IEA | 6 | 41,651,716 | 41,703,997 | RGD:2290271 | InterPro | ||
| G | TNF | tumor necrosis factor |
|
IEA | 6 | 31,543,344 | 31,546,113 | RGD:2290271 | ENSEMBL | ||
| G | TRAF3IP2 | TRAF3 interacting protein 2 |
|
IEA | 6 | 111,876,581 | 111,927,477 | RGD:2290271 | ENSEMBL | ||
| G | TREM1 | triggering receptor expressed on myeloid cells 1 |
|
TAS | 6 | 41,242,999 | 41,254,457 | RGD:2290271 | PINC | ||
| G | TREM2 | triggering receptor expressed on myeloid cells 2 |
|
TAS | 6 | 41,126,246 | 41,130,922 | RGD:2290271 | PINC | ||
| G | YTHDF2 | YTH domain family, member 2 |
|
TAS | 1 | 29,063,133 | 29,096,287 | RGD:2290271 | PINC | ||
humoral immune response mediated by circulating immunoglobulin
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL3 | B-cell CLL/lymphoma 3 |
|
IEA | 19 | 45,251,978 | 45,263,301 | RGD:2290271 | ENSEMBL | ||
| G | EXO1 | exonuclease 1 |
|
IEA | 1 | 242,011,493 | 242,053,241 | RGD:2290271 | ENSEMBL | ||
| G | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
|
IDA | 6 | 32,627,241 | 32,634,466 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
IDA | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
ISS | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 | IDA | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | ISS | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 |
|
ISS | 6 | 32,485,151 | 32,498,006 | RGD:2290271 | UniProtKB | ||
| G | ZP3 | zona pellucida glycoprotein 3 (sperm receptor) |
|
ISS | 7 | 76,026,841 | 76,071,388 | RGD:2290271 | UniProtKB | ||
immune response to tumor cell
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | MICA | MHC class I polypeptide-related sequence A |
|
IDA | 6 | 31,367,561 | 31,383,090 | RGD:2290271 | UniProtKB | ||
| G | PRF1 | perforin 1 (pore forming protein) |
|
ISS | 10 | 72,357,104 | 72,362,531 | RGD:2290271 | UniProtKB | ||
immunoglobulin mediated immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL10 | B-cell CLL/lymphoma 10 |
|
IEA | 1 | 85,731,459 | 85,742,587 | RGD:2290271 | ENSEMBL | ||
| G | CD27 | CD27 molecule |
|
NAS | 12 | 6,554,051 | 6,560,884 | RGD:2290271 | UniProtKB | ||
| G | CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain |
|
ISS | 5 | 149,781,200 | 149,792,499 | RGD:2290271 | UniProtKB | ||
| G | FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
IEA | 1 | 161,185,087 | 161,189,038 | RGD:2290271 | ENSEMBL | ||
| G | HLA-DMA | major histocompatibility complex, class II, DM alpha |
|
IEA | 6 | 32,916,391 | 32,920,899 | RGD:2290271 | ENSEMBL | ||
| G | INPP5D | inositol polyphosphate-5-phosphatase, 145kDa |
|
IEA | 2 2 |
233,925,036 234,054,795 |
233,995,880 234,116,549 |
RGD:2290271 | ENSEMBL | ||
| G | IRF7 | interferon regulatory factor 7 |
|
IEA | 11 | 612,555 | 615,999 | RGD:2290271 | ENSEMBL | ||
| G | LY9 | lymphocyte antigen 9 |
|
NAS | 1 | 160,765,864 | 160,798,045 | RGD:2290271 | UniProtKB | ||
| G | MYD88 | myeloid differentiation primary response 88 |
|
IEA | 3 | 38,179,969 | 38,184,513 | RGD:2290271 | ENSEMBL | ||
| G | PRKCD | protein kinase C, delta |
|
IEA | 3 | 53,195,223 | 53,226,733 | RGD:2290271 | ENSEMBL | ||
| G | TLR8 | toll-like receptor 8 |
|
TAS | X | 12,924,739 | 12,941,288 | RGD:2290271 | UniProtKB | ||
immunoglobulin production in mucosal tissue
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GCNT3 | glucosaminyl (N-acetyl) transferase 3, mucin type |
|
IEA | 15 | 59,903,982 | 59,912,210 | RGD:2290271 | ENSEMBL | ||
immunoglobulin production involved in immunoglobulin mediated immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
|
IDA | 6 | 32,627,241 | 32,634,466 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
IDA | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
ISS | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 | IDA | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | ISS | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 |
|
ISS | 6 | 32,485,151 | 32,498,006 | RGD:2290271 | UniProtKB | ||
| G | NOD2 | nucleotide-binding oligomerization domain containing 2 |
|
IEA | 16 | 50,731,050 | 50,766,987 | RGD:2290271 | ENSEMBL | ||
immunoglobulin secretion involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | POU2F2 | POU class 2 homeobox 2 |
|
IEA | 19 | 42,590,262 | 42,636,625 | RGD:2290271 | ENSEMBL | ||
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | RAB17 | RAB17, member RAS oncogene family |
|
ISS | 2 | 238,482,965 | 238,499,769 | RGD:2290271 | UniProtKB | ||
inflammatory response to antigenic stimulus
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AK7 | adenylate kinase 7 |
|
IEA | 14 | 96,858,448 | 96,955,764 | RGD:2290271 | ENSEMBL | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
ISS | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
|
IDA | 6 | 32,546,546 | 32,557,613 | RGD:2290271 | UniProtKB | ||
| G | HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 | IDA | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | IDA | RGD:2290271 | UniProtKB | ||||||
| G | HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 |
|
ISS | 6 | 32,485,151 | 32,498,006 | RGD:2290271 | UniProtKB | ||
| G | HMGB1 | high mobility group box 1 |
|
IEP | 13 | 31,032,877 | 31,040,081 | RGD:2290271 | UniProtKB | ||
| G | IL20RB | interleukin 20 receptor beta |
|
IEA | 3 | 136,676,707 | 136,729,927 | RGD:2290271 | ENSEMBL | ||
| G | IL25 | interleukin 25 |
|
IEA | 14 | 23,842,018 | 23,845,612 | RGD:2290271 | ENSEMBL | ||
| G | IL2RA | interleukin 2 receptor, alpha |
|
IEA | 10 | 6,052,657 | 6,104,333 | RGD:2290271 | ENSEMBL | ||
| G | IL5RA | interleukin 5 receptor, alpha |
|
IEA | 3 | 3,108,008 | 3,152,058 | RGD:2290271 | ENSEMBL | ||
| G | NOTCH1 | notch 1 |
|
IEA | 9 | 139,388,896 | 139,440,238 | RGD:2290271 | ENSEMBL | ||
| G | NOTCH2 | notch 2 |
|
IEA | 1 | 120,454,176 | 120,612,317 | RGD:2290271 | ENSEMBL | ||
| G | PNMA1 | paraneoplastic Ma antigen 1 |
|
ISS | 14 | 74,178,486 | 74,181,128 | RGD:2290271 | UniProtKB | ||
innate immune response in mucosa
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | APOA4 | apolipoprotein A-IV |
|
IDA | 11 | 116,691,418 | 116,694,011 | RGD:2290271 | BHF-UCL | ||
| G | IL4 | interleukin 4 |
|
IEA | 5 | 132,009,678 | 132,018,370 | RGD:2290271 | ENSEMBL | ||
| G | NOD2 | nucleotide-binding oligomerization domain containing 2 |
|
IEA | 16 | 50,731,050 | 50,766,987 | RGD:2290271 | ENSEMBL | ||
| G | NOS2 | nitric oxide synthase 2, inducible |
|
NAS | 17 | 26,083,792 | 26,127,555 | RGD:2290271 | BHF-UCL | ||
interleukin-4-dependent isotype switching to IgE isotypes
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
|
ISS | 1 | 173,152,870 | 173,176,471 | RGD:2290271 | BHF-UCL | ||
isotype switching
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AICDA | activation-induced cytidine deaminase |
|
IEA | 12 | 8,754,762 | 8,765,442 | RGD:2290271 | ENSEMBL | ||
| G | BATF | basic leucine zipper transcription factor, ATF-like |
|
ISS | 14 | 75,988,784 | 76,013,335 | RGD:2290271 | UniProtKB | ||
| G | CD40LG | CD40 ligand |
|
ISS | X | 135,730,336 | 135,742,549 | RGD:2290271 | UniProtKB | ||
| G | ERCC1 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
|
IEA | 19 | 45,910,591 | 45,927,177 | RGD:2290271 | ENSEMBL | ||
| G | EXO1 | exonuclease 1 |
|
IEA | 1 | 242,011,493 | 242,053,241 | RGD:2290271 | ENSEMBL | ||
| G | EXOSC3 | exosome component 3 |
|
ISS | 9 | 37,779,711 | 37,785,089 | RGD:2290271 | UniProtKB | ||
| G | EXOSC6 | exosome component 6 |
|
ISS | 16 | 70,284,134 | 70,285,833 | RGD:2290271 | UniProtKB | ||
| G | LIG4 | ligase IV, DNA, ATP-dependent |
|
ISS | 13 | 108,859,790 | 108,870,716 | RGD:2290271 | UniProtKB | ||
| G | MLH1 | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
IEA | 3 | 37,034,841 | 37,092,337 | RGD:2290271 | ENSEMBL | ||
| G | MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
|
ISS | 2 | 47,630,206 | 47,710,367 | RGD:2290271 | BHF-UCL | ||
| G | MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
|
IBA | 2 | 47,630,206 | 47,710,367 | RGD:2290271 | RefGenome | ||
| G | MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
|
IEA | 2 | 47,630,206 | 47,710,367 | RGD:2290271 | ENSEMBL | ||
| G | MSH6 | mutS homolog 6 (E. coli) |
|
ISS | 2 | 48,010,221 | 48,034,092 | RGD:2290271 | BHF-UCL | ||
| G | MSH6 | mutS homolog 6 (E. coli) |
|
IBA | 2 | 48,010,221 | 48,034,092 | RGD:2290271 | RefGenome | ||
| G | MSH6 | mutS homolog 6 (E. coli) |
|
IEA | 2 | 48,010,221 | 48,034,092 | RGD:2290271 | ENSEMBL | ||
| G | NBN | nibrin |
|
IEA | 8 | 90,945,564 | 90,996,899 | RGD:2290271 | ENSEMBL | ||
| G | RNF168 | ring finger protein 168, E3 ubiquitin protein ligase |
|
ISS | 3 | 196,195,654 | 196,230,639 | RGD:2290271 | UniProtKB | ||
| G | RNF8 | ring finger protein 8, E3 ubiquitin protein ligase |
|
ISS | 6 | 37,321,748 | 37,362,514 | RGD:2290271 | UniProtKB | ||
| G | RNF8 | ring finger protein 8, E3 ubiquitin protein ligase |
|
IEA | 6 | 37,321,748 | 37,362,514 | RGD:2290271 | ENSEMBL | ||
| G | SWAP70 | SWAP switching B-cell complex 70kDa subunit |
|
IEA | 11 | 9,685,628 | 9,774,508 | RGD:2290271 | ENSEMBL | ||
| G | XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
IEA | 5 | 82,373,317 | 82,649,579 | RGD:2290271 | ENSEMBL | ||
isotype switching to IgG isotypes
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | HSPD1 | heat shock 60kDa protein 1 (chaperonin) |
|
IDA | 2 | 198,351,308 | 198,364,998 | RGD:2290271 | BHF-UCL | ||
leukocyte activation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | SH2D1B | SH2 domain containing 1B |
|
ISS | 1 | 162,365,056 | 162,381,928 | RGD:2290271 | UniProtKB | ||
| G | SYK | spleen tyrosine kinase |
|
ISS | 9 | 93,564,012 | 93,660,842 | RGD:2290271 | UniProtKB | ||
leukocyte migration involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FUT7 | fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
|
IEA | 9 | 139,924,626 | 139,927,292 | RGD:2290271 | ENSEMBL | ||
| G | HCK | hemopoietic cell kinase |
|
TAS | 20 | 30,639,991 | 30,689,659 | RGD:2290271 | UniProtKB | ||
macrophage activation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | LBP | lipopolysaccharide binding protein |
|
ISS | 20 | 36,974,814 | 37,005,653 | RGD:2290271 | BHF-UCL | ||
| G | PRKCE | protein kinase C, epsilon |
|
IEA | 2 | 45,879,043 | 46,415,129 | RGD:2290271 | ENSEMBL | ||
| G | SBNO2 | strawberry notch homolog 2 (Drosophila) |
|
IEA | 19 | 1,107,633 | 1,174,282 | RGD:2290271 | ENSEMBL | ||
| G | SBNO2 | strawberry notch homolog 2 (Drosophila) |
|
IMP | 19 | 1,107,633 | 1,174,282 | RGD:2290271 | UniProtKB | ||
| G | SYK | spleen tyrosine kinase |
|
ISS | 9 | 93,564,012 | 93,660,842 | RGD:2290271 | UniProtKB | ||
| G | TICAM1 | toll-like receptor adaptor molecule 1 |
|
IEA | 19 | 4,815,936 | 4,831,754 | RGD:2290271 | ENSEMBL | ||
| G | TYROBP | TYRO protein tyrosine kinase binding protein |
|
IEA | 19 | 36,395,303 | 36,399,211 | RGD:2290271 | ENSEMBL | ||
macrophage cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GAS6 | growth arrest-specific 6 |
|
IEA | 13 | 114,523,522 | 114,567,046 | RGD:2290271 | ENSEMBL | ||
marginal zone B cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL3 | B-cell CLL/lymphoma 3 |
|
IEA | 19 | 45,251,978 | 45,263,301 | RGD:2290271 | ENSEMBL | ||
| G | PTK2B | protein tyrosine kinase 2 beta |
|
ISS | 8 | 27,168,999 | 27,316,908 | RGD:2290271 | UniProtKB | ||
| G | PTK2B | protein tyrosine kinase 2 beta |
|
IEA | 8 | 27,168,999 | 27,316,908 | RGD:2290271 | ENSEMBL | ||
mast cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
IDA | 4 | 55,524,095 | 55,606,881 | RGD:2290271 | UniProtKB | ||
mast cell degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CPLX2 | complexin 2 |
|
IEA | 5 | 175,223,610 | 175,311,023 | RGD:2290271 | UniProtKB | ||
| G | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
IMP | 4 | 55,524,095 | 55,606,881 | RGD:2290271 | UniProtKB | ||
| G | LAT | linker for activation of T cells |
|
IEA | 16 | 28,996,147 | 29,002,104 | RGD:2290271 | UniProtKB | ||
| G | LAT2 | linker for activation of T cells family, member 2 |
|
IEA | 7 | 73,624,087 | 73,644,164 | RGD:2290271 | UniProtKB | ||
| G | MILR1 | mast cell immunoglobulin-like receptor 1 |
|
ISS | 17 | 62,461,567 | 62,464,760 | RGD:2290271 | UniProtKB | ||
| G | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
TAS | 1 | 9,711,790 | 9,789,172 | RGD:2290271 | UniProtKB | ||
| G | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
TAS | 7 | 106,505,924 | 106,547,592 | RGD:2290271 | UniProtKB | ||
| G | S100A13 | S100 calcium binding protein A13 |
|
NAS | 1 | 153,591,275 | 153,606,568 | RGD:2290271 | UniProtKB | ||
mature B cell differentiation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GPR183 | G protein-coupled receptor 183 |
|
ISS | 13 | 99,946,789 | 99,959,749 | RGD:2290271 | UniProtKB | ||
microglial cell activation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CX3CR1 | chemokine (C-X3-C motif) receptor 1 |
|
IEA | 3 | 39,304,985 | 39,323,226 | RGD:2290271 | ENSEMBL | ||
| G | NOD2 | nucleotide-binding oligomerization domain containing 2 |
|
IEA | 16 | 50,731,050 | 50,766,987 | RGD:2290271 | ENSEMBL | ||
| G | TLR7 | toll-like receptor 7 |
|
IEA | X X |
12,885,202 12,903,630 |
12,908,480 12,908,480 |
RGD:2290271 | ENSEMBL | ||
mucosal immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | OTUD7B | OTU domain containing 7B |
|
ISS | 1 | 149,912,231 | 149,982,686 | RGD:2290271 | UniProtKB | ||
myeloid dendritic cell activation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | DOCK2 | dedicator of cytokinesis 2 |
|
ISS | 5 | 169,064,251 | 169,510,386 | RGD:2290271 | UniProtKB | ||
| G | DOCK2 | dedicator of cytokinesis 2 |
|
IEA | 5 | 169,064,251 | 169,510,386 | RGD:2290271 | ENSEMBL | ||
| G | PYCARD | PYD and CARD domain containing |
|
ISS | 16 | 31,212,807 | 31,214,097 | RGD:2290271 | UniProtKB | ||
myeloid dendritic cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CAMK4 | calcium/calmodulin-dependent protein kinase IV |
|
NOT | IMP | 5 | 110,559,947 | 110,820,749 | RGD:2290271 | UniProtKB | |
natural killer cell degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | KLRF2 | killer cell lectin-like receptor subfamily F, member 2 |
|
TAS | 12 | 10,034,088 | 10,048,432 | RGD:2290271 | UniProtKB | ||
| G | RAB27A | RAB27A, member RAS oncogene family |
|
IEA | 15 | 55,495,164 | 55,582,013 | RGD:2290271 | ENSEMBL | ||
| G | UNC13D | unc-13 homolog D (C. elegans) |
|
IEA | 17 | 73,823,306 | 73,840,798 | RGD:2290271 | ENSEMBL | ||
negative regulation of acute inflammatory response to antigenic stimulus
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) |
|
IEA | 18 | 904,944 | 912,173 | RGD:2290271 | ENSEMBL | ||
| G | VIMP | VCP-interacting membrane protein |
|
IMP | 15 | 101,811,214 | 101,817,700 | RGD:2290271 | BHF-UCL | ||
negative regulation of adaptive immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 |
|
IEA | 21 | 15,857,549 | 15,955,723 | RGD:2290271 | ENSEMBL | ||
| G | SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 |
|
ISS | 21 | 15,857,549 | 15,955,723 | RGD:2290271 | UniProtKB | ||
| G | TRIM27 | tripartite motif containing 27 |
|
IMP | 6 | 28,870,779 | 28,891,768 | RGD:2290271 | UniProtKB | ||
negative regulation of chronic inflammatory response to antigenic stimulus
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL10 | interleukin 10 |
|
IEA | 1 | 206,940,948 | 206,945,839 | RGD:2290271 | ENSEMBL | ||
negative regulation of complement activation, classical pathway
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CR1 | complement component (3b/4b) receptor 1 (Knops blood group) |
|
IDA | 1 | 207,669,473 | 207,815,110 | RGD:2290271 | UniProtKB | ||
| G | CR1 | complement component (3b/4b) receptor 1 (Knops blood group) |
|
IDA | 1 | 207,669,473 | 207,815,110 | RGD:2290271 | UniProtKB | ||
negative regulation of cytokine secretion involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | APOA1 | apolipoprotein A-I |
|
IDA | 11 | 116,706,469 | 116,708,338 | RGD:2290271 | BHF-UCL | ||
| G | APOA2 | apolipoprotein A-II |
|
IDA | 1 | 161,192,083 | 161,193,418 | RGD:2290271 | BHF-UCL | ||
| G | IL10 | interleukin 10 |
|
IDA | 1 | 206,940,948 | 206,945,839 | RGD:2290271 | BHF-UCL | ||
| G | LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
|
IDA | 19 | 55,128,629 | 55,149,007 | RGD:2290271 | UniProtKB | ||
| G | TNF | tumor necrosis factor |
|
IDA | 6 | 31,543,344 | 31,546,113 | RGD:2290271 | BHF-UCL | ||
negative regulation of dendritic cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | JAK3 | Janus kinase 3 |
|
ISS | 19 | 17,935,591 | 17,958,841 | RGD:2290271 | BHF-UCL | ||
negative regulation of eosinophil degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
ISS | 3 | 46,395,235 | 46,402,413 | RGD:2290271 | BHF-UCL | ||
negative regulation of germinal center formation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FOXJ1 | forkhead box J1 |
|
ISS | 17 | 74,132,414 | 74,137,380 | RGD:2290271 | BHF-UCL | ||
| G | FOXJ1 | forkhead box J1 |
|
IBA | 17 | 74,132,414 | 74,137,380 | RGD:2290271 | RefGenome | ||
| G | RC3H1 | ring finger and CCCH-type domains 1 |
|
ISS | 1 | 173,900,352 | 173,962,210 | RGD:2290271 | BHF-UCL | ||
negative regulation of humoral immune response mediated by circulating immunoglobulin
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FOXJ1 | forkhead box J1 |
|
ISS | 17 | 74,132,414 | 74,137,380 | RGD:2290271 | BHF-UCL | ||
| G | FOXJ1 | forkhead box J1 |
|
IBA | 17 | 74,132,414 | 74,137,380 | RGD:2290271 | RefGenome | ||
| G | PTPN6 | protein tyrosine phosphatase, non-receptor type 6 |
|
IEA | 12 | 7,055,740 | 7,070,479 | RGD:2290271 | ENSEMBL | ||
negative regulation of inflammatory response to antigenic stimulus
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GPX1 | glutathione peroxidase 1 |
|
IEA | 3 | 49,394,609 | 49,395,791 | RGD:2290271 | ENSEMBL | ||
| G | GPX2 | glutathione peroxidase 2 (gastrointestinal) |
|
IEA | 14 | 65,405,870 | 65,409,623 | RGD:2290271 | ENSEMBL | ||
| G | HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | IDA | RGD:2290271 | UniProtKB | ||||||
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
IEA | 5 | 158,741,791 | 158,757,481 | RGD:2290271 | ENSEMBL | ||
| G | NOD2 | nucleotide-binding oligomerization domain containing 2 |
|
IEA | 16 | 50,731,050 | 50,766,987 | RGD:2290271 | ENSEMBL | ||
| G | PSMB4 | proteasome (prosome, macropain) subunit, beta type, 4 |
|
IEA | 1 | 151,372,041 | 151,374,412 | RGD:2290271 | ENSEMBL | ||
negative regulation of isotype switching to IgE isotypes
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL6 | B-cell CLL/lymphoma 6 |
|
IEA | 3 | 187,439,165 | 187,463,513 | RGD:2290271 | ENSEMBL | ||
| G | FOXP3 | forkhead box P3 |
|
IBA | X | 49,106,897 | 49,121,288 | RGD:2290271 | RefGenome | ||
| G | NDFIP1 | Nedd4 family interacting protein 1 |
|
IEA | 5 | 141,488,324 | 141,534,008 | RGD:2290271 | ENSEMBL | ||
negative regulation of macrophage cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IRAK3 | interleukin-1 receptor-associated kinase 3 |
|
ISS | 12 | 66,582,978 | 66,648,402 | RGD:2290271 | BHF-UCL | ||
| G | TGFB1 | transforming growth factor, beta 1 |
|
IDA | 19 | 41,836,812 | 41,859,831 | RGD:2290271 | DFLAT | ||
| G | TGFB2 | transforming growth factor, beta 2 |
|
IDA | 1 | 218,518,676 | 218,617,961 | RGD:2290271 | DFLAT | ||
| G | TGFB3 | transforming growth factor, beta 3 |
|
IDA | 14 | 76,424,442 | 76,448,092 | RGD:2290271 | DFLAT | ||
negative regulation of mast cell activation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FER | fer (fps/fes related) tyrosine kinase |
|
ISS | 5 | 108,083,523 | 108,523,373 | RGD:2290271 | UniProtKB | ||
negative regulation of mast cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL6 | B-cell CLL/lymphoma 6 |
|
IEA | 3 | 187,439,165 | 187,463,513 | RGD:2290271 | ENSEMBL | ||
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
IEA | 22 | 35,777,060 | 35,790,207 | RGD:2290271 | ENSEMBL | ||
negative regulation of mast cell degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FOXF1 | forkhead box F1 |
|
IEA | 16 | 86,544,133 | 86,548,070 | RGD:2290271 | ENSEMBL | ||
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
IEA | 22 | 35,777,060 | 35,790,207 | RGD:2290271 | ENSEMBL | ||
negative regulation of memory T cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IFNL1 | interferon, lambda 1 |
|
IDA | 19 | 39,786,965 | 39,789,312 | RGD:2290271 | UniProtKB | ||
negative regulation of natural killer cell differentiation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | PGLYRP1 | peptidoglycan recognition protein 1 |
|
IEA | 19 | 46,522,411 | 46,526,556 | RGD:2290271 | ENSEMBL | ||
| G | PGLYRP2 | peptidoglycan recognition protein 2 |
|
IEA | 19 | 15,579,456 | 15,590,315 | RGD:2290271 | ENSEMBL | ||
| G | PGLYRP3 | peptidoglycan recognition protein 3 |
|
IEA | 1 | 153,270,338 | 153,283,194 | RGD:2290271 | ENSEMBL | ||
| G | PGLYRP4 | peptidoglycan recognition protein 4 |
|
IEA | 1 | 153,302,596 | 153,321,022 | RGD:2290271 | ENSEMBL | ||
negative regulation of neutrophil degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABR | active BCR-related |
|
IEA | 17 | 906,758 | 1,090,616 | RGD:2290271 | ENSEMBL | ||
| G | BCR | breakpoint cluster region |
|
IEA | 22 | 23,522,552 | 23,660,224 | RGD:2290271 | ENSEMBL | ||
negative regulation of plasmacytoid dendritic cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BST2 | bone marrow stromal cell antigen 2 |
|
IDA | 19 | 17,513,755 | 17,516,384 | RGD:2290271 | UniProtKB | ||
negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
|
IDA | 19 | 55,128,629 | 55,149,007 | RGD:2290271 | UniProtKB | ||
negative regulation of T cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FOXP3 | forkhead box P3 |
|
IDA | X | 49,106,897 | 49,121,288 | RGD:2290271 | UniProtKB | ||
| G | XCL1 | chemokine (C motif) ligand 1 |
|
IDA | 1 | 168,545,711 | 168,551,315 | RGD:2290271 | BHF-UCL | ||
negative regulation of T cell mediated cytotoxicity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL7R | interleukin 7 receptor |
|
IEA | 5 | 35,856,977 | 35,879,705 | RGD:2290271 | ENSEMBL | ||
| G | LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
|
IDA | 19 | 55,128,629 | 55,149,007 | RGD:2290271 | UniProtKB | ||
| G | PPP3CB | protein phosphatase 3, catalytic subunit, beta isozyme |
|
IEA | 10 | 75,196,563 | 75,255,782 | RGD:2290271 | ENSEMBL | ||
| G | PTPRC | protein tyrosine phosphatase, receptor type, C |
|
ISS | 1 | 198,608,098 | 198,726,605 | RGD:2290271 | UniProtKB | ||
| G | PTPRC | protein tyrosine phosphatase, receptor type, C |
|
IEA | 1 | 198,608,098 | 198,726,605 | RGD:2290271 | ENSEMBL | ||
negative regulation of T cell mediated immunity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | NOD2 | nucleotide-binding oligomerization domain containing 2 |
|
IEA | 16 | 50,731,050 | 50,766,987 | RGD:2290271 | ENSEMBL | ||
negative regulation of T-helper 1 cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL4R | interleukin 4 receptor |
|
IEA | 16 | 27,325,230 | 27,376,099 | RGD:2290271 | ENSEMBL | ||
| G | JAK3 | Janus kinase 3 |
|
ISS | 19 | 17,935,591 | 17,958,841 | RGD:2290271 | BHF-UCL | ||
| G | TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
|
ISS | 1 | 173,152,870 | 173,176,471 | RGD:2290271 | BHF-UCL | ||
negative regulation of T-helper 1 type immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL1RL1 | interleukin 1 receptor-like 1 |
|
IEA | 2 | 102,927,962 | 102,968,497 | RGD:2290271 | ENSEMBL | ||
| G | IL33 | interleukin 33 |
|
IEA | 9 | 6,215,786 | 6,257,983 | RGD:2290271 | ENSEMBL | ||
| G | XCL1 | chemokine (C motif) ligand 1 |
|
IC | 1 | 168,545,711 | 168,551,315 | RGD:2290271 | BHF-UCL | ||
negative regulation of T-helper 17 cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL4 | interleukin 4 |
|
IEA | 5 | 132,009,678 | 132,018,370 | RGD:2290271 | ENSEMBL | ||
negative regulation of T-helper 2 cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IFNA2 | interferon, alpha 2 |
|
IDA | 9 | 21,384,254 | 21,385,396 | RGD:2290271 | UniProtKB | ||
| G | IFNB1 | interferon, beta 1, fibroblast |
|
IDA | 9 | 21,077,104 | 21,077,943 | RGD:2290271 | UniProtKB | ||
negative regulation of T-helper 2 cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL6 | B-cell CLL/lymphoma 6 |
|
IEA | 3 | 187,439,165 | 187,463,513 | RGD:2290271 | ENSEMBL | ||
| G | HLX | H2.0-like homeobox |
|
IEA | 1 | 221,052,743 | 221,058,401 | RGD:2290271 | ENSEMBL | ||
| G | SOCS5 | suppressor of cytokine signaling 5 |
|
ISS | 2 | 46,926,099 | 46,989,927 | RGD:2290271 | UniProtKB | ||
negative regulation of T-helper cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | RC3H1 | ring finger and CCCH-type domains 1 |
|
ISS | 1 | 173,900,352 | 173,962,210 | RGD:2290271 | BHF-UCL | ||
negative regulation of type IV hypersensitivity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL20RB | interleukin 20 receptor beta |
|
IEA | 3 | 136,676,707 | 136,729,927 | RGD:2290271 | ENSEMBL | ||
| G | SPN | sialophorin |
|
IEA | 16 | 29,674,271 | 29,681,828 | RGD:2290271 | ENSEMBL | ||
neutrophil activation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
IEA | 1 | 161,185,087 | 161,189,038 | RGD:2290271 | ENSEMBL | ||
| G | SYK | spleen tyrosine kinase |
|
ISS | 9 | 93,564,012 | 93,660,842 | RGD:2290271 | UniProtKB | ||
| G | TYROBP | TYRO protein tyrosine kinase binding protein |
|
IEA | 19 | 36,395,303 | 36,399,211 | RGD:2290271 | ENSEMBL | ||
neutrophil degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ANXA3 | annexin A3 |
|
IDA | 4 | 79,472,742 | 79,531,605 | RGD:2290271 | UniProtKB | ||
| G | MYO1F | myosin IF |
|
IEA | 19 | 8,585,674 | 8,642,331 | RGD:2290271 | ENSEMBL | ||
| G | PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
|
IEA | 4 | 74,852,156 | 74,853,907 | RGD:2290271 | InterPro | ||
| G | STXBP2 | syntaxin binding protein 2 |
|
IEP | 19 | 7,701,991 | 7,712,759 | RGD:2290271 | UniProtKB | ||
| G | STXBP3 | syntaxin binding protein 3 |
|
IEP | 1 | 109,289,285 | 109,352,148 | RGD:2290271 | UniProtKB | ||
| G | VAMP7 | vesicle-associated membrane protein 7 |
|
ISS | X Y |
155,110,943 59,213,949 |
155,173,433 59,276,439 |
RGD:2290271 | UniProtKB | ||
plasma cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | LGALS1 | lectin, galactoside-binding, soluble, 1 |
|
IEA | 22 | 38,071,613 | 38,075,809 | RGD:2290271 | ENSEMBL | ||
| G | LGALS8 | lectin, galactoside-binding, soluble, 8 |
|
IEA | 1 | 236,681,514 | 236,716,281 | RGD:2290271 | ENSEMBL | ||
| G | NKX2-3 | NK2 homeobox 3 |
|
IEA | 10 | 101,292,690 | 101,296,281 | RGD:2290271 | ENSEMBL | ||
positive regulation of acute inflammatory response to antigenic stimulus
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CNR1 | cannabinoid receptor 1 (brain) |
|
IEA | 6 | 88,849,583 | 88,875,767 | RGD:2290271 | ENSEMBL | ||
positive regulation of adaptive immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) |
|
IC | 5 | 55,230,923 | 55,290,821 | RGD:2290271 | BHF-UCL | ||
| G | PYCARD | PYD and CARD domain containing |
|
IMP | 16 | 31,212,807 | 31,214,097 | RGD:2290271 | UniProtKB | ||
| G | SIRT1 | sirtuin 1 |
|
IDA | 10 | 69,644,427 | 69,678,147 | RGD:2290271 | UniProtKB | ||
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | DEFB103A | defensin, beta 103A |
|
TAS | 8 | 7,286,410 | 7,287,682 | RGD:2290271 | UniProtKB | ||
positive regulation of chronic inflammatory response to antigenic stimulus
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | LTA | lymphotoxin alpha (TNF superfamily, member 1) |
|
IEA | 6 | 31,539,876 | 31,542,101 | RGD:2290271 | ENSEMBL | ||
| G | TNF | tumor necrosis factor |
|
IEA | 6 | 31,543,344 | 31,546,113 | RGD:2290271 | ENSEMBL | ||
positive regulation of cytokine secretion involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
|
IDA | 5 | 76,114,833 | 76,131,140 | RGD:2290271 | UniProtKB | ||
| G | WNT5A | wingless-type MMTV integration site family, member 5A |
|
IMP | 3 | 55,499,743 | 55,521,670 | RGD:2290271 | UniProtKB | ||
positive regulation of dendritic cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | NOD2 | nucleotide-binding oligomerization domain containing 2 |
|
IEA | 16 | 50,731,050 | 50,766,987 | RGD:2290271 | ENSEMBL | ||
positive regulation of eosinophil degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
|
IDA | 5 | 76,114,833 | 76,131,140 | RGD:2290271 | UniProtKB | ||
positive regulation of gamma-delta T cell activation involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
|
IDA | 19 | 55,128,629 | 55,149,007 | RGD:2290271 | UniProtKB | ||
positive regulation of germinal center formation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADA | adenosine deaminase |
|
IEA | 20 | 43,248,163 | 43,280,376 | RGD:2290271 | ENSEMBL | ||
| G | TNFRSF13C | tumor necrosis factor receptor superfamily, member 13C |
|
IEA | 22 | 42,321,036 | 42,322,821 | RGD:2290271 | ENSEMBL | ||
| G | TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b |
|
IEA | 13 | 108,921,977 | 108,960,832 | RGD:2290271 | ENSEMBL | ||
positive regulation of humoral immune response mediated by circulating immunoglobulin
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) |
|
IEA | 19 | 7,753,643 | 7,767,032 | RGD:2290271 | ENSEMBL | ||
| G | GIMAP5 | GTPase, IMAP family member 5 |
|
IEA | 7 | 150,434,436 | 150,440,737 | RGD:2290271 | ENSEMBL | ||
| G | HPX | hemopexin |
|
IEA | 11 | 6,452,268 | 6,462,254 | RGD:2290271 | ENSEMBL | ||
| G | LTA | lymphotoxin alpha (TNF superfamily, member 1) |
|
IEA | 6 | 31,539,876 | 31,542,101 | RGD:2290271 | ENSEMBL | ||
| G | NOD2 | nucleotide-binding oligomerization domain containing 2 |
|
IEA | 16 | 50,731,050 | 50,766,987 | RGD:2290271 | ENSEMBL | ||
| G | PTPRC | protein tyrosine phosphatase, receptor type, C |
|
IEA | 1 | 198,608,098 | 198,726,605 | RGD:2290271 | ENSEMBL | ||
| G | TNF | tumor necrosis factor |
|
IEA | 6 | 31,543,344 | 31,546,113 | RGD:2290271 | ENSEMBL | ||
positive regulation of hypersensitivity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
ISS | 17 | 38,710,021 | 38,721,736 | RGD:2290271 | BHF-UCL | ||
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
IEA | 17 | 38,710,021 | 38,721,736 | RGD:2290271 | ENSEMBL | ||
positive regulation of immune response to tumor cell
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | HRG | histidine-rich glycoprotein |
|
IDA | 3 | 186,383,798 | 186,396,023 | RGD:2290271 | UniProtKB | ||
positive regulation of immunoglobulin mediated immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CD226 | CD226 molecule |
|
IDA | 18 | 67,530,192 | 67,624,232 | RGD:2290271 | BHF-UCL | ||
| G | PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) |
|
IMP | 19 | 45,349,393 | 45,392,485 | RGD:2290271 | BHF-UCL | ||
| G | TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
|
ISS | 1 | 173,152,870 | 173,176,471 | RGD:2290271 | BHF-UCL | ||
positive regulation of immunoglobulin production in mucosal tissue
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | XCL1 | chemokine (C motif) ligand 1 |
|
ISS | 1 | 168,545,711 | 168,551,315 | RGD:2290271 | BHF-UCL | ||
positive regulation of inflammatory response to antigenic stimulus
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CD28 | CD28 molecule |
|
IEA | 2 | 204,571,198 | 204,603,635 | RGD:2290271 | ENSEMBL | ||
positive regulation of isotype switching
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | PAXIP1 | PAX interacting (with transcription-activation domain) protein 1 |
|
ISS | 7 | 154,735,400 | 154,794,682 | RGD:2290271 | UniProtKB | ||
positive regulation of isotype switching to IgA isotypes
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | TGFB1 | transforming growth factor, beta 1 |
|
IDA | 19 | 41,836,812 | 41,859,831 | RGD:2290271 | MGI | ||
| G | TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 |
|
IDA | 17 | 7,461,609 | 7,464,925 | RGD:2290271 | MGI | ||
positive regulation of isotype switching to IgE isotypes
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CLCF1 | cardiotrophin-like cytokine factor 1 |
|
ISS | 11 | 67,131,639 | 67,141,648 | RGD:2290271 | BHF-UCL | ||
| G | IL4 | interleukin 4 |
|
ISS | 5 | 132,009,678 | 132,018,370 | RGD:2290271 | UniProtKB | ||
| G | STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced |
|
IEA | 12 | 57,489,187 | 57,505,196 | RGD:2290271 | ENSEMBL | ||
positive regulation of isotype switching to IgG isotypes
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CD28 | CD28 molecule |
|
IEA | 2 | 204,571,198 | 204,603,635 | RGD:2290271 | ENSEMBL | ||
| G | CD40 | CD40 molecule, TNF receptor superfamily member 5 |
|
IEA | 20 | 44,746,906 | 44,758,384 | RGD:2290271 | ENSEMBL | ||
| G | IFNG | interferon, gamma |
|
IEA | 12 | 68,548,550 | 68,553,521 | RGD:2290271 | ENSEMBL | ||
| G | IL2 | interleukin 2 |
|
IEA | 4 | 123,372,625 | 123,377,650 | RGD:2290271 | ENSEMBL | ||
| G | IL4 | interleukin 4 |
|
ISS | 5 | 132,009,678 | 132,018,370 | RGD:2290271 | UniProtKB | ||
| G | PTPRC | protein tyrosine phosphatase, receptor type, C |
|
IEA | 1 | 198,608,098 | 198,726,605 | RGD:2290271 | ENSEMBL | ||
| G | TBX21 | T-box 21 |
|
IEA | 17 | 45,810,610 | 45,823,485 | RGD:2290271 | ENSEMBL | ||
positive regulation of macrophage cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CD36 | CD36 molecule (thrombospondin receptor) |
|
IEA | 7 | 80,231,504 | 80,308,593 | RGD:2290271 | ENSEMBL | ||
| G | CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain |
|
ISS | 5 | 149,781,200 | 149,792,499 | RGD:2290271 | BHF-UCL | ||
| G | SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
|
ISS | 15 | 74,701,630 | 74,726,299 | RGD:2290271 | UniProtKB | ||
| G | SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
|
IEA | 15 | 74,701,630 | 74,726,299 | RGD:2290271 | ENSEMBL | ||
| G | TLR2 | toll-like receptor 2 |
|
IEA | 4 | 154,605,441 | 154,627,243 | RGD:2290271 | ENSEMBL | ||
| G | TLR4 | toll-like receptor 4 |
|
IEA | 9 | 120,466,453 | 120,479,769 | RGD:2290271 | ENSEMBL | ||
| G | WNT5A | wingless-type MMTV integration site family, member 5A |
|
IMP | 3 | 55,499,743 | 55,521,670 | RGD:2290271 | UniProtKB | ||
positive regulation of mast cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL10 | B-cell CLL/lymphoma 10 |
|
NAS | 1 | 85,731,459 | 85,742,587 | RGD:2290271 | UniProtKB | ||
| G | FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
IEA | 1 | 161,185,087 | 161,189,038 | RGD:2290271 | ENSEMBL | ||
positive regulation of mast cell degranulation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ADORA2B | adenosine A2b receptor |
|
IEA | 17 | 15,848,231 | 15,879,210 | RGD:2290271 | ENSEMBL | ||
| G | ADORA3 | adenosine A3 receptor |
|
IEA | 1 | 112,025,970 | 112,106,597 | RGD:2290271 | ENSEMBL | ||
| G | CRHR1 | corticotropin releasing hormone receptor 1 |
|
IEA | 17 | 43,697,710 | 43,913,194 | RGD:2290271 | ENSEMBL | ||
| G | FCER1A | Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
IEA | 1 | 159,253,678 | 159,278,014 | RGD:2290271 | ENSEMBL | ||
| G | FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
IEA | 1 | 161,185,087 | 161,189,038 | RGD:2290271 | ENSEMBL | ||
| G | FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
ISS | 1 | 27,938,800 | 27,961,727 | RGD:2290271 | UniProtKB | ||
| G | FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
IEA | 1 | 27,938,800 | 27,961,727 | RGD:2290271 | ENSEMBL | ||
| G | GAB2 | GRB2-associated binding protein 2 |
|
ISS | 11 | 77,926,336 | 78,128,868 | RGD:2290271 | UniProtKB | ||
| G | MS4A2 | membrane-spanning 4-domains, subfamily A, member 2 |
|
IEA | 11 | 59,856,137 | 59,865,940 | RGD:2290271 | ENSEMBL | ||
| G | SYK | spleen tyrosine kinase |
|
IEA | 9 | 93,564,012 | 93,660,842 | RGD:2290271 | ENSEMBL | ||
positive regulation of memory T cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
ISS | 5 | 158,741,791 | 158,757,481 | RGD:2290271 | BHF-UCL | ||
| G | IL12RB1 | interleukin 12 receptor, beta 1 |
|
ISS | 19 | 18,170,371 | 18,197,697 | RGD:2290271 | BHF-UCL | ||
| G | IL23A | interleukin 23, alpha subunit p19 |
|
ISS | 12 | 56,732,663 | 56,734,194 | RGD:2290271 | BHF-UCL | ||
| G | IL23R | interleukin 23 receptor |
|
ISS | 1 | 67,632,169 | 67,725,662 | RGD:2290271 | BHF-UCL | ||
| G | TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
|
ISS | 1 | 173,152,870 | 173,176,471 | RGD:2290271 | BHF-UCL | ||
positive regulation of myeloid leukocyte cytokine production involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
IEA | 22 | 24,236,565 | 24,237,409 | RGD:2290271 | ENSEMBL | ||
positive regulation of natural killer cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | GIMAP5 | GTPase, IMAP family member 5 |
|
IEA | 7 | 150,434,436 | 150,440,737 | RGD:2290271 | ENSEMBL | ||
| G | IL21 | interleukin 21 |
|
IEA | 4 | 123,533,783 | 123,542,212 | RGD:2290271 | ENSEMBL | ||
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CD226 | CD226 molecule |
|
IMP | 18 | 67,530,192 | 67,624,232 | RGD:2290271 | BHF-UCL | ||
| G | CRTAM | cytotoxic and regulatory T cell molecule |
|
IDA | 11 | 122,709,255 | 122,743,347 | RGD:2290271 | HGNC | ||
| G | IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
|
IDA | 3 | 159,706,623 | 159,713,806 | RGD:2290271 | UniProtKB | ||
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
IDA | 5 | 158,741,791 | 158,757,481 | RGD:2290271 | UniProtKB | ||
| G | PVR | poliovirus receptor |
|
IMP | 19 | 45,147,098 | 45,169,429 | RGD:2290271 | BHF-UCL | ||
| G | PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) |
|
IMP | 19 | 45,349,393 | 45,392,485 | RGD:2290271 | BHF-UCL | ||
positive regulation of peripheral T cell tolerance induction
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FOXP3 | forkhead box P3 |
|
IBA | X | 49,106,897 | 49,121,288 | RGD:2290271 | RefGenome | ||
positive regulation of T cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
IMP | 18 | 56,338,618 | 56,417,370 | RGD:2290271 | UniProtKB | ||
| G | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 |
|
IMP | 6 | 91,223,292 | 91,297,020 | RGD:2290271 | UniProtKB | ||
| G | SASH3 | SAM and SH3 domain containing 3 |
|
IEA | X | 128,913,892 | 128,929,177 | RGD:2290271 | ENSEMBL | ||
| G | TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
|
ISS | 1 | 173,152,870 | 173,176,471 | RGD:2290271 | BHF-UCL | ||
| G | TRAF2 | TNF receptor-associated factor 2 |
|
IMP | 9 | 139,780,965 | 139,821,067 | RGD:2290271 | UniProtKB | ||
| G | TRAF6 | TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
IMP | 11 | 36,505,317 | 36,531,863 | RGD:2290271 | UniProtKB | ||
| G | XCL1 | chemokine (C motif) ligand 1 |
|
ISS | 1 | 168,545,711 | 168,551,315 | RGD:2290271 | BHF-UCL | ||
positive regulation of T cell mediated cytotoxicity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
|
IBA | 12 | 123,405,498 | 123,451,056 | RGD:2290271 | RefGenome | ||
| G | B2M | beta-2-microglobulin |
|
IEA | 15 | 45,003,685 | 45,010,357 | RGD:2290271 | ENSEMBL | ||
| G | IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
|
IDA | 3 | 159,706,623 | 159,713,806 | RGD:2290271 | UniProtKB | ||
| G | IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
|
IDA | 3 | 159,706,623 | 159,713,806 | RGD:2290271 | UniProtKB | ||
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
ISS | 5 | 158,741,791 | 158,757,481 | RGD:2290271 | BHF-UCL | ||
| G | IL12RB1 | interleukin 12 receptor, beta 1 |
|
ISS | 19 | 18,170,371 | 18,197,697 | RGD:2290271 | BHF-UCL | ||
| G | IL23A | interleukin 23, alpha subunit p19 |
|
ISS | 12 | 56,732,663 | 56,734,194 | RGD:2290271 | BHF-UCL | ||
| G | IL23R | interleukin 23 receptor |
|
ISS | 1 | 67,632,169 | 67,725,662 | RGD:2290271 | BHF-UCL | ||
| G | P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 |
|
IEA | 12 | 121,570,622 | 121,624,354 | RGD:2290271 | ENSEMBL | ||
| G | PTPRC | protein tyrosine phosphatase, receptor type, C |
|
IEA | 1 | 198,608,098 | 198,726,605 | RGD:2290271 | ENSEMBL | ||
| G | TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
|
IBA | 6 | 32,812,986 | 32,821,748 | RGD:2290271 | RefGenome | ||
| G | TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
|
IBA | 6 | 32,789,610 | 32,806,547 | RGD:2290271 | RefGenome | ||
| G | XCL1 | chemokine (C motif) ligand 1 |
|
IDA | 1 | 168,545,711 | 168,551,315 | RGD:2290271 | BHF-UCL | ||
positive regulation of T cell mediated immune response to tumor cell
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | HSPD1 | heat shock 60kDa protein 1 (chaperonin) |
|
IDA | 2 | 198,351,308 | 198,364,998 | RGD:2290271 | BHF-UCL | ||
positive regulation of T cell mediated immunity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL1B | interleukin 1, beta |
|
IC | 2 | 113,587,337 | 113,594,356 | RGD:2290271 | BHF-UCL | ||
positive regulation of T-helper 1 cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | XCL1 | chemokine (C motif) ligand 1 |
|
ISS | 1 | 168,545,711 | 168,551,315 | RGD:2290271 | BHF-UCL | ||
positive regulation of T-helper 1 cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CCL19 | chemokine (C-C motif) ligand 19 |
|
ISS | 9 | 34,689,567 | 34,691,274 | RGD:2290271 | BHF-UCL | ||
| G | CD80 | CD80 molecule |
|
NAS | 3 | 119,243,140 | 119,278,481 | RGD:2290271 | UniProtKB | ||
| G | HLX | H2.0-like homeobox |
|
IEA | 1 | 221,052,743 | 221,058,401 | RGD:2290271 | ENSEMBL | ||
| G | RIPK2 | receptor-interacting serine-threonine kinase 2 |
|
IEA | 8 | 90,769,975 | 90,803,292 | RGD:2290271 | ENSEMBL | ||
| G | SOCS5 | suppressor of cytokine signaling 5 |
|
ISS | 2 | 46,926,099 | 46,989,927 | RGD:2290271 | UniProtKB | ||
positive regulation of T-helper 1 type immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
ISS | 3 | 46,395,235 | 46,402,413 | RGD:2290271 | BHF-UCL | ||
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
ISS | 5 | 158,741,791 | 158,757,481 | RGD:2290271 | BHF-UCL | ||
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
IDA | 5 | 158,741,791 | 158,757,481 | RGD:2290271 | BHF-UCL | ||
| G | IL12RB1 | interleukin 12 receptor, beta 1 |
|
ISS | 19 | 18,170,371 | 18,197,697 | RGD:2290271 | BHF-UCL | ||
| G | IL12RB1 | interleukin 12 receptor, beta 1 |
|
IDA | 19 | 18,170,371 | 18,197,697 | RGD:2290271 | BHF-UCL | ||
| G | IL23A | interleukin 23, alpha subunit p19 |
|
ISS | 12 | 56,732,663 | 56,734,194 | RGD:2290271 | BHF-UCL | ||
| G | IL23A | interleukin 23, alpha subunit p19 |
|
IDA | 12 | 56,732,663 | 56,734,194 | RGD:2290271 | BHF-UCL | ||
| G | IL23A | interleukin 23, alpha subunit p19 |
|
TAS | 12 | 56,732,663 | 56,734,194 | RGD:2290271 | BHF-UCL | ||
| G | IL23A | interleukin 23, alpha subunit p19 |
|
NAS | 12 | 56,732,663 | 56,734,194 | RGD:2290271 | BHF-UCL | ||
| G | IL23R | interleukin 23 receptor |
|
ISS | 1 | 67,632,169 | 67,725,662 | RGD:2290271 | BHF-UCL | ||
| G | IL23R | interleukin 23 receptor |
|
IDA | 1 | 67,632,169 | 67,725,662 | RGD:2290271 | BHF-UCL | ||
| G | IL27RA | interleukin 27 receptor, alpha |
|
IEA | 19 | 14,142,552 | 14,163,731 | RGD:2290271 | ENSEMBL | ||
| G | NLRP10 | NLR family, pyrin domain containing 10 |
|
ISS | 11 | 7,981,156 | 7,985,059 | RGD:2290271 | UniProtKB | ||
| G | RIPK2 | receptor-interacting serine-threonine kinase 2 |
|
IEA | 8 | 90,769,975 | 90,803,292 | RGD:2290271 | ENSEMBL | ||
| G | SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
|
ISS | 2 | 219,246,752 | 219,261,617 | RGD:2290271 | BHF-UCL | ||
positive regulation of T-helper 17 cell lineage commitment
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
ISS | 5 | 158,741,791 | 158,757,481 | RGD:2290271 | BHF-UCL | ||
| G | IL12RB1 | interleukin 12 receptor, beta 1 |
|
ISS | 19 | 18,170,371 | 18,197,697 | RGD:2290271 | BHF-UCL | ||
| G | IL23A | interleukin 23, alpha subunit p19 |
|
ISS | 12 | 56,732,663 | 56,734,194 | RGD:2290271 | BHF-UCL | ||
| G | IL23R | interleukin 23 receptor |
|
ISS | 1 | 67,632,169 | 67,725,662 | RGD:2290271 | BHF-UCL | ||
positive regulation of T-helper 17 type immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
ISS | 5 | 158,741,791 | 158,757,481 | RGD:2290271 | BHF-UCL | ||
| G | IL12RB1 | interleukin 12 receptor, beta 1 |
|
ISS | 19 | 18,170,371 | 18,197,697 | RGD:2290271 | BHF-UCL | ||
| G | IL23A | interleukin 23, alpha subunit p19 |
|
ISS | 12 | 56,732,663 | 56,734,194 | RGD:2290271 | BHF-UCL | ||
| G | IL23R | interleukin 23 receptor |
|
ISS | 1 | 67,632,169 | 67,725,662 | RGD:2290271 | BHF-UCL | ||
| G | NLRP10 | NLR family, pyrin domain containing 10 |
|
ISS | 11 | 7,981,156 | 7,985,059 | RGD:2290271 | UniProtKB | ||
| G | PRKCQ | protein kinase C, theta |
|
ISS | 10 | 6,469,105 | 6,622,254 | RGD:2290271 | UniProtKB | ||
positive regulation of T-helper 2 cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | PRKCZ | protein kinase C, zeta |
|
ISS | 1 | 1,981,909 | 2,116,834 | RGD:2290271 | UniProtKB | ||
| G | PRKCZ | protein kinase C, zeta |
|
IEA | 1 | 1,981,909 | 2,116,834 | RGD:2290271 | ENSEMBL | ||
| G | RSAD2 | radical S-adenosyl methionine domain containing 2 |
|
ISS | 2 | 7,017,796 | 7,038,363 | RGD:2290271 | UniProtKB | ||
| G | XCL1 | chemokine (C motif) ligand 1 |
|
ISS | 1 | 168,545,711 | 168,551,315 | RGD:2290271 | BHF-UCL | ||
positive regulation of T-helper 2 cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CD86 | CD86 molecule |
|
NAS | 3 | 121,774,209 | 121,839,990 | RGD:2290271 | UniProtKB | ||
| G | IL4R | interleukin 4 receptor |
|
IEA | 16 | 27,325,230 | 27,376,099 | RGD:2290271 | ENSEMBL | ||
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
IEA | 7 | 22,766,766 | 22,771,621 | RGD:2290271 | ENSEMBL | ||
| G | PRKCZ | protein kinase C, zeta |
|
ISS | 1 | 1,981,909 | 2,116,834 | RGD:2290271 | UniProtKB | ||
| G | PRKCZ | protein kinase C, zeta |
|
IEA | 1 | 1,981,909 | 2,116,834 | RGD:2290271 | ENSEMBL | ||
| G | RARA | retinoic acid receptor, alpha |
|
IDA | 17 | 38,465,423 | 38,513,895 | RGD:2290271 | BHF-UCL | ||
| G | TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
|
ISS | 1 | 173,152,870 | 173,176,471 | RGD:2290271 | BHF-UCL | ||
positive regulation of T-helper cell differentiation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | MYB | v-myb myeloblastosis viral oncogene homolog (avian) |
|
IMP | 6 | 135,502,453 | 135,540,311 | RGD:2290271 | UniProtKB | ||
positive regulation of type I hypersensitivity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FCER1A | Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
IEA | 1 | 159,253,678 | 159,278,014 | RGD:2290271 | ENSEMBL | ||
| G | FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
IEA | 1 | 161,185,087 | 161,189,038 | RGD:2290271 | ENSEMBL | ||
positive regulation of type IIa hypersensitivity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | C3 | complement component 3 |
|
IEA | 19 | 6,677,846 | 6,720,662 | RGD:2290271 | ENSEMBL | ||
| G | FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
IEA | 1 | 161,185,087 | 161,189,038 | RGD:2290271 | ENSEMBL | ||
positive regulation of type III hypersensitivity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
IEA | 1 | 161,185,087 | 161,189,038 | RGD:2290271 | ENSEMBL | ||
positive regulation of type IV hypersensitivity
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ZP3 | zona pellucida glycoprotein 3 (sperm receptor) |
|
ISS | 7 | 76,026,841 | 76,071,388 | RGD:2290271 | UniProtKB | ||
regulation of adaptive immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | DUSP10 | dual specificity phosphatase 10 |
|
IEA | 1 | 221,874,764 | 221,915,516 | RGD:2290271 | ENSEMBL | ||
| G | IRF1 | interferon regulatory factor 1 |
|
TAS | 5 | 131,817,301 | 131,826,465 | RGD:2290271 | UniProtKB | ||
| G | IRF7 | interferon regulatory factor 7 |
|
IDA | 11 | 612,555 | 615,999 | RGD:2290271 | UniProtKB | ||
| G | TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
|
ISS | 1 | 173,152,870 | 173,176,471 | RGD:2290271 | BHF-UCL | ||
regulation of B cell cytokine production
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BTK | Bruton agammaglobulinemia tyrosine kinase |
|
TAS | X | 100,604,435 | 100,641,212 | RGD:2290271 | UniProtKB | ||
regulation of cytokine production involved in immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | TRIL | TLR4 interactor with leucine-rich repeats |
|
IDA | 7 | 28,992,974 | 28,998,029 | RGD:2290271 | UniProtKB | ||
regulation of germinal center formation
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | BCL6 | B-cell CLL/lymphoma 6 |
|
NAS | 3 | 187,439,165 | 187,463,513 | RGD:2290271 | UniProtKB | ||
| G | MEF2A | myocyte enhancer factor 2A |
|
IEA | 15 | 100,106,133 | 100,256,630 | RGD:2290271 | ENSEMBL | ||
| G | MEF2C | myocyte enhancer factor 2C |
|
ISS | 5 | 88,014,058 | 88,199,922 | RGD:2290271 | UniProtKB | ||
| G | MEF2C | myocyte enhancer factor 2C |
|
IEA | 5 | 88,014,058 | 88,199,922 | RGD:2290271 | ENSEMBL | ||
| G | RC3H1 | ring finger and CCCH-type domains 1 |
|
ISS | 1 | 173,900,352 | 173,962,210 | RGD:2290271 | BHF-UCL | ||
| G | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
|
ISS | 6 | 138,188,325 | 138,204,451 | RGD:2290271 | BHF-UCL | ||
| G | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
|
IEA | 6 | 138,188,325 | 138,204,451 | RGD:2290271 | ENSEMBL | ||
regulation of humoral immune response
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | CD37 | CD37 molecule |
|
IEA | 19 | 49,838,677 | 49,843,863 | RGD:2290271 | ENSEMBL | ||
| G | CXCL13 | chemokine (C-X-C motif) ligand 13 |
|
NAS | 4 | 78,432,907 | 78,532,988 | RGD:2290271 | BHF-UCL | ||
regulation of isotype switching
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | IL10 | interleukin 10 |
|
NAS | 1 | 206,940,948 | 206,945,839 | RGD:2290271 | UniProtKB | ||
| G | IL4 | interleukin 4 |
|
TAS | 5 | 132,009,678 | 132,018,370 | RGD:2290271 | UniProtKB | ||
regulation of isotype switching to IgG isotypes
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FOXP3 | forkhead box P3 |
|
||||||||




browse the term